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Staphylococcus aureus is an important human pathogen in both community and 
health care settings. Biggest challenges with S. aureus as a pathogen are its ability to 
acquire antibiotic resistance and produce robust biofilms. In this work, we investigated 
the nature of the cell wall defect in the msaABCR operon mutant in the Mu50 (VISA) and 
USA300 LAC methicillin-resistant Staphylococcus aureus (MRSA) strains. Results 
showed that msaABCR-mutant cells had decreased cell wall thickness and cell wall 
crosslinking in both strains.  These defects are most likely due to increased murein 
hydrolase activity and/or nonspecific processing of murein hydrolases mediated by 
increased protease activity in mutant cells. The defect was enhanced by a decrease in 
teichoic acid content in the msaABCR mutant cell wall. Moreover, we also observed 
significantly downregulated transcription of early cell wall-synthesizing genes, 
supporting the finding that msaABCR-mutant cells have decreased peptidoglycan 
synthesis. Thus, we conclude that the msaABCR operon controls the balance between cell 
wall synthesis and cell wall hydrolysis, which is required for maintaining a robust cell 
wall and acquiring resistance to cell wall-targeting antibiotics, such as vancomycin and 
the β-lactams. 
This dissertation also elucidated the mechanism of the cell death phenomenon 
regulated by the msaABCR operon at the molecular level in the USA300 LAC strain. This 
study showed that msaABCR represses weak acid-dependent cell death. Rate of glucose 
consumption, and acetate and acetoin production in msaABCR mutant was higher than 
the USA300 LAC (wild type) strain in the biofilm microenvironment, which caused 
increased intracellular acidification and led to increased cell death. We showed that 
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MsaB binds directly to the promoter region of LysR-type transcriptional regulator, cidR 
gene and represses expression of the cidR regulon. We also showed role of MsaB in 
indirect repression of pyruvate catabolism via cidR to play an important role in overflow 
metabolism and programmed cell death during biofilm development in S. aureus. In 
addition, pyruvate was also shown to induce expression of the msaABCR operon. This 
article has thus deciphered the role of the msaABCR operon in staphylococcal metabolic 
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CHAPTER I - LITERATURE REVIEW 
1.1 Staphylococcus aureus in human health 
Staphylococcus aureus is a gram positive, spherical bacterium of 0.7-1.2 μm 
diameter. This catalase and coagulase positive bacterium belong to the phylum 
Firmicutes, class Bacilli, and family Staphylococcaceae. Dr. Alexander Ogston first 
discovered the staphylococci family and coined the term “staphylococci” in 1982, noting 
the grape-like clusters of micrococci from microscopic examination of surgical pus 
abscesses from an infected patient (1). Soon after in 1884, Dr. Anton Rosenbach noticed 
two differently pigmented staphylococcus species in solid medium and gave the name 
Staphylococcus aureus (S. aureus) for its ‘aurum’ or golden pigmentation and S. albus to 
indicate white colonies, which is later changed to S. epidermidis as they were highly 
prevalent on skin (2). Coagulase positive test (based on blood plasma clotting ability), 
positive heat stable deoxyrobinuclease (Dnase) test, positive protein A hemagglutination 
test and catalase positive test are used for identification and differentiation of S. aureus 
(3).  
S. aureus is an opportunistic pathogenic bacterium capable of colonizing anterior 
nares, pharynx and skin of both humans and animals (4, 5). 80 – 90 % of the human 
populations are persistently or intermittently colonized by S. aureus. High prevalence of 
asymptomatic carriage of S. aureus in humans suggests its commensal existence as 
normal flora in human body. However, colonized elderly and immune compromised 
individuals are in risk for developing S. aureus infections.  
Staphylococcus aureus was initially thought to cause nosocomial infections, as it 
infected more hospital patients in with chronic diseases and immunocompromised 
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condition and patients requiring hospital medical devices like catheters, prosthetic joints, 
pacemaker, heart valves etc. However, increased incidence of community acquired 
methicillin resistant S. aureus (CA-MRSA) infections are reported in major US cities (6). 
In addition to North American countries, it has reached to South America, Asia, Europe 
and Australia (7). Staph infections majorly MRSA infections, alone resulted in more than 
120,000 hospitalizations, 20,000 deaths and excess of 4-30 billion dollars in healthcare 
related economic burden in the USA in 2017 (8, 9). Staph infections ranges from mild 
minor (e.g., skin and soft tissue infections) to life threatening infections (e.g., toxic shock, 
osteomyelitis, endocarditis, meningitis, and septicemia) (10-12). Its ability to infect 
almost every organ system in the body causing high morbidity and mortality is mainly 
due to its ability to produce diverse virulence factors, form biofilm, acquire of antibiotic 
resistance, and evade and invade the host immune cells (11-13). Despite staph infection 
posing as a serious public health threat impacting many lives and economies worldwide, 
vaccine against S. aureus hasn’t been developed yet.  
1.2 S. aureus Cell wall Synthesis and autolysins 
S. aureus, gram-positive bacteria have robust complex multilayered cell wall 
made up of meshwork of peptidoglycan (PG), transversed with wall teichoic acid (WTA), 
and wall-associated surface proteins (14, 15). Peptidoglycan is a macromolecule made of 
glycan chains crosslinked by pentapeptide chains, which is further crosslinked by 
pentaglycine bridges. Peptidoglycan is essential for maintaining an intact cell wall to 
withstand internal turgor pressure as well as to maintain enough plasticity to allow for 
growth, division, and survival of the bacterial population (14, 16, 17). Wall teichoic acids 
(WTAs) are the most abundant anionic glycopolymers linked to the peptidoglycans in 
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Gram-positive cell walls.  WTAs are involved in a variety of processes, such as stress 
resistance (antimicrobial peptides, antimicrobial fatty acids, cationic antibiotics, heat, and 
osmolarity) and pathogenesis (host attachment, colonization, infection, and biofilm 
formation) (18). WTAs also determine the localization of penicillin-binding proteins 
(PBPs) in the cell wall; coordinate the localization, stability, and/or activity of murein 
hydrolases; and confer resistance against host-produced lytic enzymes, such as lysozymes 
(14, 16, 19). Thus, peptidoglycan and WTAs are critical bacterial components for 
maintaining cell wall structure and promoting antibiotic resistance.  
Peptidoglycan, the major component in the bacterial cell wall, is a dynamic 
structure that undergoes constant and concomitant synthesis and degradation during cell 
growth. Proper balance between these two opposite processes, synthesis and autolysis is 
essential for cell growth, cell replication, cell wall turnover, and recycling of 
muropeptides to maintain intact and robust cell wall.  
Initial steps of staphylococcal peptidoglycan biosynthesis begin inside the cell in 
cytoplasm synthesizing UDP-N-acetylglucosamine. UDP-D-N-acetylglucosamine (UDP-
D-GlcNAc) is synthesized from glucosamine-1-phosphate which in turn derived from 
glycolytic metabolite Fructose-6 phosphate and/or glucosamine in series of enzymatic 
steps catalyzed by GlmS/M/U enzymes. UDP-D-GlcNAc is also biosynthetic precursor 
for peptidoglycan, the bacterial capsule, and teichoic acids (20). For peptidoglycan 
synthesis, UDP-GlcNAc then reacts with phosphoenolpyruvate, another glycolytic 
intermediate synthesizing UDP-N-acetyl-muramic acid (UDP-MurNAc) catalyzed by 
MurA and MurB. Series of amino acids L-Ala, D-Glu, and L-Lys and the dipeptide D-
Ala-D-Ala were attached one after another to UDP-MurNAc in the enzymatic reactions 
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catalyzed Mur ligases (MurC-F) producing Park’s nucleotide (UDP-MurNAc-L-Ala-D-
Glu-L-Lys-D-Ala-D-Ala).  Park’s nucleotide is then joined to the lipid carrier 
undecaprenyl-diphosphate by activity of membrane translocase MraY, generating 
membrane-bound lipid I. UDP-GlcNAc is then attached to the lipid I, to give membrane 
bound lipid II to which pentaglycine chain was attached by activity of FemX/A/B 
proteins.  Pentaglycine-lipid II complex is then transported across membrane to outside 
of the membrane. Penicillin binding proteins (PBP) then finally adds lipid II to the 
nascent peptidoglycan chain via transglycosylation. Transpeptidase activity of PBPs links 
pentaglycine chain in one precursor molecule to the 4th D-Ala residue in pentapeptide 
chain in another peptidoglycan heteropolymer, releasing the last D-Ala residue. Major 
steps in cell wall synthesis and its inhibitors are shown in figure 1.1. 
Vancomycin is glycopeptide antibiotics capable of binding to the D-Ala-D-ala 
residue in PG monomer (Park’s nucleotide) leading to inhibition of PBPs transpeptidase 
activity, consequently blocking nascent peptidoglycan synthesis. Methicillin-susceptible 
Staphylococcus aureus has four PBPs, PBP1-4, while methicillin-resistance S. aureus 
(MRSA) has five PBPs. The fifth PBP, PBP2A has very low affinity to β-lactam, thus is 
major factor for β-lactam resistance (21). PBP1 with transpeptidase (TPase) activity, and 
PBP2 with both the transglycosylase and transpeptidase activity are essential in MSSA 
playing role in cell division and separation (22, 23). PBP2 is not essential in MRSA 
strains, as transpeptidase activity of PBP2 can be compensated with PBP2A activity (24). 
PBP3 and PBP4 have non-essential function, while PBP4 have important role in 
acquiring β-lactam resistance particularly in community acquired MRSA strains (25-27). 
Other than PBPs, two monofunctional tranglycosylases, MGT and SgtA, and two 
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accessory proteins, FmtA and FmtB, with putative transpeptidases activity, are encoded 
in S. aureus genome, indicating their function in cell wall synthesis (28-30). 
 
Figure 1. 1 Antibiotics targeting intracellular and extracellular enzymatic steps in 
S. aureus cell wall synthesis. (Source: McCallum et al, 2010 (16)) 
S. aureus can produce multiple diverse murein hydrolases, endopeptidases, N-
acetylmuramyl-L-alanine amidases, N-acetylmuramidases, N-acetylglucosaminidases, 
and transglycosylases that can cleave specifically covalent bonds of peptidoglycan (Fig. 
1.2). These enzymes, which can hydrolyze peptidoglycan of its own bacterial cell wall, 
are called autolysins. The autolysins have a major function during cell wall turnover, cell 
replication cycle, and antibiotic-induced cell autolysis (31-33). Analysis of  
Staphylococcus aureus murein hydrolases using zymography have shown more than 20 
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bacteriolytic bands, indicating production of diverse murein hydrolases by S. aureus. (34) 
However, only three (Atl A, Sle1/aaa, and LytM), are extensively studied and shown to 
have important function in maintenance of cell wall integrity. The major murein 
hydrolase AtlA, in S. aureus is cell surface protein and autolytic enzyme, which is 
synthesized as 138-kDa bifunctional precursor protein. Atl protein contains signal 
peptide, a pro-peptide, a N-acetylmuramyl-L-alanine amidase (AM) catalytic domain, 
three repeats (R1-R3), and N-acetylglucosaminidase(GL) domain at C-terminal  which is 
proteolytically processed to yield the two important autolysins, a 62-kDa N-
acetylmuramyl-L-alanine amidase and a 51-kDa N-acetylglucosaminidase (18). The 
amidase enzyme with catalytic domain and two (R1 and R2) repeat domains determining 
localization and substrate recognition, lyse the amide linkage joing N-acetyl muramic 
acid in the glycan chain and L-alanine in pentapeptide chain. While glucosaminidase 
containing single repeat domain (R3), lyse the covalent linkage between N-acetyl-β-D-
glucosamine and N-acetyl muramic in PG glycan chain (33, 35-38).  
Both LytM with glycylglycine endopeptidase activity, and Sle1 with N-
acetylmuramyl-L-alanine activity are 32k Da, making difficult to separate them in 
zymogram analysis (39, 40). Sle-1 and LytM are involved in cell growth and cell division 
(41-43). Recent study showed important function of Sle1 in acquiring β-Lactam 
Resistance (40). Other several less characterized and putative murein hydrolases having 
N-acetylmuramyl-L-alanine amidases activity including LytA (23 kDa), LytH (33kDa) 




Figure 1. 2 Murein hydrolases and their site of action in peptidoglycan. ( Source: 
Szweda et al, 2012 (45) and  Silva, 2015 (46)) 
The integrity of cell wall is indispensable for survival of bacterium and its 
synthesis is targeted by most effective and widely used antibiotics including, β-lactams 
(e.g., penicillins, methicillin and cephalosporins), glycopeptides (e.g., vancomycin and 
teicoplanin), daptomycin, bacitracin, fosfomycin, nisin, and many others (13, 16, 47). 
Small changes in cell wall plays important role in antibiotic resistance not only because 
they are target of many antibiotics, also other antibiotic should transverse through cell 
wall before they reach their site of action (47). Most of the drugs used in Staphylococcus-
related infections target cell wall biosynthesis, and this has resulted in increased 
prevalence of resistance to these drugs, which is a major health concern (13). 
1.3 Antibiotic treatment and resistance in Staphylococcus aureus 
One of the key problems with S. aureus as a pathogen is the acquisition of 
antibiotic resistance such is the case with methicillin-resistant S. aureus (MRSA) strains. 
It has acquired resistance against most of cell wall targeting antibiotics causing major 
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problems in terms of public health. CDC has classified as staph infections as a very 
serious health risk due to increased resistance to many antibiotics including last resort 
drugs (48).  
With the accidental discovery of penicillin in 1928 by Sir Howard Fleming gave a 
sigh of relief for treatment of S. aureus infections with excessive mortality rate 
particularly bacteremia (82%) in pre antibiotic era (48). However, within 20 years of 
penicillin discovery, seven naturally occurring strains of penicillin-resistant S. aureus 
(PRSA) were discovered which were found to produce penicillinase, enzyme hydrolyzing 
ß-lactam rings of penicillin inactivating it. 80% of S. aureus strains in early 1960s were 
estimated to be penicillin resistant with an extra-chromosomal plasmid containing genes 
for synthesis of penicillinase (7). With the widespread PRSA infections, semi-synthetic 
penicillin variant antibiotic resistant to ß-lactamase, methicillin, were used for the 
treatment of PRSA infections (47). However, within two years of its usage, methicillin-
resistant S. aureus (MRSA) surfaced later leading to new waves of hospital acquired 
MRSA (HA-MRSA) epidemics in the North America (7, 47). ß-lactam antibiotics, 
penicillin and methicillin block cell wall biosynthesis and bacterial growth by binding 
penicillin binding proteins (PBPs) and inactivating it. Horizontal transfer of mecA gene 
carrying mobile genetic element staphylococcal cassette chromosome mec (SCCmec) is 
reasoned to be genetic basis of resistance against ß-lactams including methicillin (7, 15). 
However, there are a number of additional auxiliary factors that are critical for resistance 
to β-lactam antibiotics (13, 49, 50). mecA encodes for PBP2A protein, having minimal 
affinity towards ß-lactams compared to native PBPs, thus PBP2A activity can 
compensate for cell wall biosynthesis inhibition caused by antibiotics (51-53). While S. 
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aureus was originally believed to be a nosocomial pathogen with MRSA outbreaks 
limited to immunocompromised patients in the hospital setting, increased incidence of 
CA-MRSA infections in community setting has increased threats in terms of its 
management and treatment.  
Vancomycin is the last resort drug used for treatment of  the S. aureus infections 
especially used for patients with extreme allergy to ß-lactams or used in case of all 
antibiotic treatment failure (54). The emergence of vancomycin intermediate S. aureus 
(VISA) in the late 1990s and vancomycin resistant S. aureus (VRSA) in the early 2000s 
has added further challenges in the field of staph infection treatment. Different types of 
point mutations causing thickened cell wall and decreased autolysins are attributed for 
emergence of VISA (15, 54). While, natural interspecies gene transfer of vancomycin 
resistance gene from a co-isolate E. faecalis to S. aureus is reasoned for origin of VRSA 
(15).  
Studies have shown that β-lactam and glycopeptide antibiotics disrupt 
peptidoglycan crosslinking, which ultimately weakens the integrity of the bacterial cell 
wall, leading to cell lysis. Due to the efficacy and safety profiles of these antibiotics, 
resensitization of resistant pathogens to these drugs is a promising approach in treatment 
of resistant pathogens (47). Several recent studies have uncovered the role of other 
factors/genes involved in the biosynthesis of cell envelope components (such as 
peptidoglycan and teichoic acids), in modulating cell wall hydrolase activities of β-
lactams, and in vancomycin resistance. These reports have rekindled interest in targeting 
genes involved in the maintenance of cell wall integrity and ultimately resensitizing 
resistant strains (16, 45, 49, 55-61). 
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1.4 Staphylococcal biofilm 
A growing concern in S. aureus treatment is the increase in formation of biofilms 
within host tissues and on implanted medical devices, leading to systemic diseases such 
as bacteremia, osteomyelitis, and endocarditis as well as chronic wound infections (11, 
12, 62). Biofilms are structured communities of bacteria in which bacteria stick together 
or to a surface by self-produced polymeric sticky molecules, including, but not limited to, 
polysaccharides, such as polysaccharide intercellular adhesin (PIA), extracellular DNA, 
and proteins (63). S. aureus biofilms demonstrate a characteristic sequence of attachment, 
accumulation/maturation, exodus, tower formation and dispersal during its development 
(63). Biofilm confers protection against antibiotics, stimulates resistance against 
clearance by the host immune response, and supports spread from the infection site (63, 
64). Therefore, studying bacterial biofilms and the mechanisms of their formation and 
maintenance can lead to a new knowledge on combating infections. To tackle this urgent 
issue, it is imperative that bacterial research identifies new strategies for inhibiting the 
development of biofilms and antibiotic resistance.  
1.5 Regulation of cell death during biofilm formation  
Programmed cell death (PCD) is a phenomenon of some cells undergoing suicidal 
mechanism for the benefit of whole organism and is well defined in eukaryotes (65, 66). 
The concept of PCD has been extended to prokaryotes that develop multicellular 
communities, such as bacterial biofilms, with a particular focus on the production of 
extracellular DNA (eDNA) and marked cell death and lysis in bacterial biofilms (65-67). 
The main purpose of bacterial PCD is thought to be the release of genomic DNA, 
proteins, and polysaccharides that serve as constituents of the biofilm matrix. However, 
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this process is a well-balanced phenomenon, as several bacterial mutants defective in 
lysis and the release of eDNA are poor biofilm formers (65, 68-74). The Staphylococcus 
aureus LysR-type transcriptional regulator, CidR, is shown to be transcriptional activator 
of the cidABC, lrgAB, and alsSD operons, together forming an interlinked CidR regulon. 
CidR regulon has been shown to have regulatory function in overflow metabolism, 
autolysis and cell death in biofilm microenvironments (68-75). Several researches have 
indicated that CidA and LrgA form putative holin–antiholin systems, respectively, 
sharing common features with the bacteriophage holin–antiholin system (72, 74, 76). In 
addition to the cidA–lrgA holin–antiholin system, other genes, such as cidC and alsSD, 
regulate stationary phase cell death by modulating overflow metabolism in S. aureus (69-
71, 73, 75).  
CidR is LysR-type transcriptional regulator (LTTR), which is thought to primarily 
activated by binding of small inducer molecule to ligand binding conserved domain. 
Several studies suggest pyruvate to be inducer molecule for activation of cidR when 
grown in excess glucose condition under acidic condition, however it’s not 
experimentally proven yet (69, 75). While cidR is shown to be main transcriptional 
activator of cidABC and alsSD, other regulators like srrAB, ccpA is also shown to 
involved in complex regulatory network of these operons (68, 70, 71, 73, 75, 77). SrrAB 
two component system, which is shown to respond to nitric oxide stress and oxygen 
availability, also appears to regulate expression of cidABC (68, 78). In addition, in 
concert with observation that excess glucose induce cidABC expression, and ccpA being 
master regulator of carbohydrate metabolism, ccpA and cidR both are mandatory for full 




1.6 Overview of staphylococcal metabolism 
Bacterial metabolism involves synthesis of macromolecules and energy sources 
needed for survival and growth. Carbohydrates mainly glucose, fructose, galactose 
primarily catabolized through glycolysis and the pentose phosphate pathway. Glycolysis 
catabolizes one molecule of glucose yielding two molecules of pyruvate, two molecules 
of ATP, and reduce two molecules of NAD+ to NADH (81, 82).  
The pyruvate catabolic fate is mainly decided based on growth conditions, and the 
oxygen availability, and availability of readily catabolizable carbon sources. Under 
anaerobic condition, pyruvate undergoes mixed-acid fermentation, producing primarily 
lactate, and other metabolites such as formate, acetate, and ethanol, resulting reoxidation 
of NADH to NAD+ required for the continuation of glycolysis. In aerobic condition, 
pyruvate dehydrogenase complex catalyze the decarboxylation of pyruvate to acetyl 
coenzyme A (acetyl-CoA) and CO2, and reduce one molecule of NAD+ to NADH (81). 
Acetyl-CoA is then fluxed to tricarboxylic acid (TCA) cycle for its complete oxidation 
and/or is incompletely oxidized to acetate by the phosphotransacetylase-acetate kinase 
(Pta-AckA) pathway, based on the nutrient availability and growth condition (83, 84).  
TCA cycle activity is very low when readily catabolizable carbohydrate and glutamate or 
glutamine are available on growth medium via carbon catabolite repression (CCR) (85, 
86). In S. aureus, CCR is mediated by Hpr and CcpA (86, 87). High levels of fructose 1,6 
bis-phosphate produced during glycolysis lead to phosphorylation and activation of HprK 
kinase, leading to phosphorylation and activation of Hpr (79, 86). Fructose-1,6-
bisphosphate and glucose-6-phosphate promote the association of phosphorylated Hpr 
 
13 
with CcpA (81). The CcpA-Hpr regulates specific genes with CRE sites as a 
transcriptional repressor or activator (81). The CRE site is typically found within the 
transcription initiation or promoter sequences when CcpA acts as a repressor, and 
upstream of the promoter sequence when it acts as a positive regulator (86).  
 
Figure 1. 3 Figure depicting glucose catabolism pathway and major precursors 
for cell envelope macromolecules by S. aureus. Green colored pathways indicate major pathways during the 
exponential growth phase, while red colored pathways in the post exponential growth phase. (Adapted from Cox et al, 2021  (88)) 
  
Under nutrient rich condition or exponential growth condition, very low amount 
of acetyl-CoA is fluxed to TCA cycle (79, 86). Therefore, acetyl-CoA undergo pta-ack 
pathway to generate acetic acid (acetogenesis) (83, 84). When nutrients (e.g., glucose) 
depleted from growth media accumulating growth-inhibitory metabolites such as lactic 
acid and acetic acid, bacteria can’t further bolster continuous growth exiting exponential 
growth phase. Under post exponential growth phase, carbon catabolite repression is 
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relieved to derepress TCA cycle, leading to increased TCA cycle function (81, 89, 90). 
Acetate accumulated in growth medium thus can be re-imported and directed to TCA 
cycle (89). Thus, S. aureus shows classic diauxic growth when grown in TSB. Acetate is 
Acetyl-coA is then regenerated from acetate via catalysis by acetyl-CoA 
synthetase/acetyl-CoA ligase (82, 91). Acetyl-CoA then can enter the TCA cycle via a 
condensation reaction with oxaloacetate catalyzed by citrate synthase. TCA cycle 
provides biosynthetic intermediates for amino acid and nucleic acid biosynthetic 
pathways, ATP, and reducing potential (NADH, FADH).  
  During aerobic growth, electrons from NADH are first transferred to 
menaquinone by the NADH dehydrogenase complex, then to oxidized cytochrome c, and 
finally to oxygen by cytochrome c oxidase forming electron transfer chain. Water is 
generated and protons are pumped out across the membrane to produce a pH and 
electrochemical gradient in this process. Reactive oxygen species (ROS) are generated as 
byproduct. ATP synthesis occurs via FoF1 ATP synthase complex by energy of pH and 
electrochemical gradient. Protons are returned to the cytoplasm by way of the Fo subunit 
in this process (81, 82). 
1.7 Overflow metabolism and biofilm formation in Staphylococcus aureus. 
CidABC expression dynamics in staphylococcal biofilm microcolonies is shown 
to mimic planktonic growth in TSB medium supplemented with excess (>35mM) glucose 
(69). Under such growth medium with excessive glucose, S. aureus is shown to undergo 
overflow metabolism triggering CidR regulon involved in PCD. Overflow metabolism is 
a wasteful strategy of catabolizing excess nutrients through incomplete oxidation, even 
under aerobic conditions, resulting in fewer energy metabolites produced per glucose 
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molecule than the energy-efficient respiration pathway (69). S. aureus overflow 
metabolism involves catabolism of excess pyruvate produced by increased glycolytic flux 
that exceeds its TCA flux, resulting in non-TCA-cycle formation of acetate via the 
AckA–Pta and CidC pathways, of acetoin via the AlsSD pathway, and of 2,3-butanediol 
via the ButA pathway as shown in figure 1.5 (69-71, 73, 83, 84, 92). Interestingly, two 
genes under the control of the CidR regulon, cidC (pyruvate:menaquinone 
oxidoreductase) and alsSD (α‐acetolactate synthetase/decarboxylase), have enzymatic 
products that utilize the same substrate, pyruvate, thus producing acetate and acetoin, 
respectively (69, 71, 73, 92). These two metabolites have been shown to affect cell death 
antithetically, suggesting a close interrelationship between pyruvate metabolism and cell 
death. cidC-encoded pyruvate oxidase promotes cell death in stationary phase by 
increasing acidification of the culture medium via the production of acetate (69). The 
negatively charged acetate can’t diffuse membrane freely (61). However, with increased 
acetate, pH of the environment drops and approaches the isoelectric point of acetate 
(~4.8) increasing protonation of acetate to neutral acetic acid. Neutral acetic acid can then 
freely move across the membrane inside the bacterial cell and in the cytoplasm leading to 
increased killing of bacterial cell. Increased intracellular weak acids in cytoplasm is 
thought to decreases the cytoplasmic pH, leading to the misfolding or unfolding of 
proteins as well as reduce the functionality of the electron transport chain to induce 
formation of ROS (69). The alsSD operon produce α-acetolactate synthase (AlsS) and α-
acetolactate decarboxylase (AlsD), which catabolize pyruvate to acetoin, which in turn 
can be processed further by acetoin reductase (ButA) to create 2,3-butanediol (69, 70, 
73). The synthesis of acetoin and 2,3-butanediol (both neutral metabolites) redirects 
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pyruvate catabolism away from the cidC pathway as well as actively consumes protons, 
promoting a neutral environment (69).  
1.8 Pyruvate metabolism and its role in staphylococcal virulence regulation 
Pyruvate, a simplest α-keto acid, is an important metabolite derived from 
catabolism of sugars via glycolysis as the end product. It’s a central metabolite for 
different pathways including glucose catabolism, TCA cycle, and lactate, acetate, fatty 
acid, carotenoid, undecaprenyl phosphate (UP) and amino acid syntheses pathways (81, 
93, 94). Pyruvate is a major metabolic signal molecule for the expression of secreted 
proteins. It is shown alter exoproteome of USA300 including many virulence 
determinants mainly leucocidins (94). Pyruvate is highly prevalent metabolite in the 
human host, ranging from 40 μM to 10 mM in diabetic patients (94-96). Diabetic 
individuals are shown to be more susceptible to S. aureus infections including pneumonia 
and foot infections supporting notion that pyruvate enhance pathogenicity of S. aureus 
during infection (97-99). As a central metabolite in center of multiple crucial pathways, 
regulation of fate of pyruvate and maintenance of its homeostasis is important for S. 
aureus metabolic adaptation and virulence. 
1.9 msaABCR operon is involved in cell wall biosynthesis, antibiotic Resistance, and 
biofilm development in Staphylococcus aureus. 
msaABCR operon is a four-gene operon composed of msaA, msaB, msaC, and 
msaR antisense RNA (Fig 1.4) (100). msaA, msaC, and msaR codes for three functional 
noncoding RNAs which is speculated to have function in regulation of the msaB 
expression. msaB is the only gene of the entire operon that encodes a MsaB (cspA) 
protein which acts as a transcription factor as well as RNA chaperone binding to 213 
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mRNAs (100-104). msaABCR operon is shown to regulates expression of sarA, biofilm 
development, virulence, antibiotic resistance, and persistence in S. aureus (100-102, 105-
109).  RNA transcriptomic analysis revealed involvement of msaABCR operon in 
regulating expression of 287 genes important in staphylococcal pathogenesis in MRSA 
USA300 LAC strain suggesting importance of MsaB as a global regulator in S. aureus 
(107). 
 
Figure 1. 4 Simplified figure representing structure of the msaABCR operon. Four 
genes in msaABCR operon and its putative promoter are represented in Figure (Source: Sahukhal et al., 2014 (100)). 
 
1.9.1 Role of msaABCR operon in cell wall biosynthesis, antibiotic Resistance  
Deletion of the msaABCR operon resulted in decreases in the vancomycin 
minimum inhibitory concentration (MIC) in VISA strains (Mu50, HIP6297, and LIM2) 
and in a MRSA strain (USA300 LAC) of S. aureus (107, 109). In addition, we also 
observed significant reductions of cell wall thickness in the Mu50 and HIP6297 strains 
(109). We have also shown that msaABCR mutants are defective in persister cell 
formation under cell wall-targeting antibiotic (vancomycin and daptomycin) stress 
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conditions in the USA300 LAC strain background (107). Increases in Triton X-100-
induced autolysis and protease production are also major phenotypes of the msaABCR-
deletion mutant (109, 110). We have previously shown that the msaABCR operon 
represses protease activity regulating the expression of four extracellular proteases (Aur, 
Scp, Ssp, and Spl) in various growth phases, including the early exponential growth phase 
(100, 110). The serine protease Ssp, the cysteine proteases, as well as other proteases 
have been found to be involved in the processing of AtlA, thereby regulating murein 
hydrolase activities and autolysis (110-113). These findings indicate a role for the 
msaABCR operon in cell wall synthesis, autolysis, and the development of vancomycin 
resistance. We therefore hypothesized that the msaABCR operon plays a role in 
maintaining cell wall integrity by regulating both cell wall synthesis and cell wall 
hydrolase activity. In this study we investigated the mechanism behind the cell wall 
defect (reduction of cell wall thickness), the increased cell autolysis, and the 
vancomycin/-lactam susceptibility in the msaABCR-deletion mutant in both the VISA 
Mu50 and MRSA USA300 LAC strains. 
1.9.2 Role of msaABCR operon in biofilm development 
Studies have delineated a significant decrease in biofilm thickness as well as a 
significant increase in cell death with the deletion of this msaABCR operon in S. aureus 
(108). Notably, it was suggested that this observed defective biofilm development in 
msaABCR mutant could be a result of uncontrolled cell death (108). Our transcriptomics 
and proteomics data demonstrated role of msaABCR operon in regulation of expression of 
hundreds of genes, including repression of TCA cycle, overflow metabolic pathways and 
amino acid catabolic pathways (107). This connection between the msaABCR operon, 
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autolysis, and bacterial cell death during biofilm development is an interesting 
relationship, which requires further study (Fig 1.5). In this study, we further elucidated 
interrelation between msaABCR operon (MsaB) and CidR regulon to regulate pyruvate 
homeostasis, overflow metabolism and programmed cell death during biofilm 
development. 
 
Figure 1. 5 Overview of cidR regulon, overflow metabolic pathways and programmed cell 
death phenomenon. Dashed line represents major research questions regarding role of msaABCR operon in overflow 
metabolism and cell death during biofilm development. 
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CHAPTER II – SIGNIFICANCE, HYPOTHSIS AND INNOVATION 
2.1 Significance  
Key Characteristics of Staphylococcus aureus as a successful pathogen is its 
ability to produce diverse virulence factors, acquire antibiotic resistance, ability to form 
robust biofilm and physiological and metabolic adaptability. Pathogenic bacteria are 
continuously in contention with several environmental, antibiotic and host stressors 
including immune systems (82). To counter several stressors and adverse environments, 
S. aureus have adapted several strategies including acquiring antibiotic resistance, 
producing diverse virulence factors, developed intricate mechanism of metabolic 
adaptation and persistence. In this dissertation, I deciphered the novel regulatory role of 
msaABCR in regulating staphylococcal overflow metabolism and weak acid mediated 
cell death during biofilm development. I also uncovered role of msaABCR operon in 
maintaining cell wall integrity and its role in antibiotic resistance. This new knowledge 
on maintenance of cell wall structure, mechanism of antibiotic resistance and range of 
metabolic adaptations employed by staphylococci during biofilm development would 
significantly contribute towards designing novel therapeutic and treatment strategies to 




msaABCR operon is shown to regulate antibiotic resistance, murein hydrolase 
activity and cell death during biofilm development in Staphylococcus aureus (100, 108, 
109). Our transcriptomics and proteomics data also suggested that msaABCR regulating 
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overflow metabolic pathways, and cell wall synthesis and autolysis pathways (107). 
Based on these observations we hypothesized that msaABCR operon plays important role 
in maintenance of cell wall structure, and regulation of cell death mechanism and 
metabolic adaptation during biofilm development. In this dissertation, I tested these 
hypotheses by pursuing the following specific aims: 
Specific Aim 1: To define how msaABCR regulates staphylococcal cell wall synthesis 
and autolysin activity to determine cell wall integrity and antibiotic resistance. 
Deletion of the msaABCR operon resulted in decreases in the vancomycin 
minimum inhibitory concentration (MIC) and significant reductions of cell wall thickness 
in VISA strains (107, 109). In addition, increases in Triton X-100-induced autolysis and 
protease production were also major phenotypes of the msaABCR-deletion mutant (109, 
110). Based on these observations, we hypothesized that the msaABCR operon plays a 
role in maintaining cell wall integrity by regulating both cell wall synthesis and cell wall 
hydrolase activity. In this study we investigated the mechanism behind the cell wall 
defect (reduction of cell wall thickness), the increased cell autolysis, and the 
vancomycin/-lactam susceptibility in the msaABCR-deletion mutant in both the VISA 
Mu50 and MRSA USA300 LAC strains.  
Specific Aim 2: To define the role of the msaABCR operon in programmed cell 
death Staphylococcal overflow metabolism to regulate biofilm Development. 
Several studies have shown importance of PCD in biofilm formation in S. aureus 
(68-71, 114) Previous researches have showed an increased cell death phenotype in 
msaABCR mutant biofilm (108). Based on transcriptomic data, msaABCR operon has 
shown to repress cidABC transcription. In this study we investigated cidABC - dependent 
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cell death phenomenon in msaABCR mutant. We also examined regulation of cidR 
regulon and overflow metabolism by MsaB. 
Specific Aim 3: To define how central metabolite pyruvate regulates expression and 
activity of msaABCR (MsaB). 
Pyruvate is a critical metabolite in center of several important pathways, acts as a 
signal metabolite.  Pyruvate is also shown to affect staphylococcal metabolic flux 
exoproteins expression (94) and thought to be inducer molecule of CidR (69). Thus, we 
hypothesized that msaABCR operon represses pyruvate catabolic pathways of 
Staphylococcus aureus sensing pyruvate or other metabolites of central metabolism. In 
this work, we attempted to study molecular mechanism behind how msaABCR respond to 
pyruvate to regulate pyruvate homeostasis. 
2.3 Innovation  
Understanding intricate relationship between metabolism and staphylococcal 
pathogenesis is growing field of research interest. In this premise, our study showed the 
involvement of the msaABCR operon in staphylococcal metabolism. msaABCR operon 
deletion caused decreased antibiotic resistance, decreased virulence, and defective 
biofilm development in S. aureus. These findings suggest the possibility that inactivation 
of the operon may help in overcoming treatment failures associated with antibiotic 
resistance and biofilm associated infections. Additionally, this study would lead us to 
better understanding of intricate relationship between msaABCR operon, staphylococcal 




CHAPTER III – EXPERIMENTAL APPROACHES 
3.1 Bacteria and growth conditions 
All the bacterial strains used in this study are described in Table 3.1. We used a 
representative strain for each of the two clinically significant antibiotic-resistant S. aureus 
strains. These were Mu50, a known vancomycin-intermediate S. aureus (VISA) isolate, 
and community-acquired MRSA strain USA300 LAC, a vancomycin-sensitive S. aureus 
isolate (VSSA). The allelic replacement method was used to generate msaABCR-deletion 
mutants in strains Mu50 and USA300 LAC (109, 115). For trans-complementation, the 
msaABCR region was cloned into the pCN34 low-copy vector with the modification of 
changing the kanamycin selectable marker to a chloramphenicol-resistant marker, as 
described previously (109). Plasmid constructs were moved into specific strain using 
Escherichia coli strain DH5α and the restriction-deficient S. aureus laboratory strain 
RN4220 via transformation and phage transduction. 
S. aureus strains were grown in tryptic soy agar (TSA) or tryptic soy broth (TSB). 
Overnight bacterial cultures were prepared by inoculating cells from frozen culture stocks 
into culture tubes containing 5 mL of freshly prepared TSB or Mueller-Hinton broth 
(MHB) (TSB; Becton, Dickinson and Company, MD, USA) and incubating at 37°C with 
continuous shaking at 225 rpm. The overnight cultures were diluted 1:10 in fresh 
medium, incubated for 2 hours, and then normalized to an optical density at 600 nm 
(OD600) of 0.05 to use as the starting culture for experiments. For growth in the presence 
of protease inhibitors, one Mini EDTA-free Protease Inhibitor Cocktail tablet (Roche) 




3.2 Transmission electron microscopy  
Preparation and examination of S. aureus cells by transmission electron 
microscopy were performed as described previously with some modifications (109). 
Briefly, exponentially growing cells were fixed in 2% paraformaldehyde and 2.5% 
glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.4, for 2 hours at RT and treated 
with 1% osmium tetroxide in 0.1 M sodium cacodylate buffer for 1 hour at 4°C. Cells 
were dehydrated in a graded ethanol series, infiltrated with (1:1) acetone:(Spurs) epoxy 
resin overnight, immersed in freshly made 100% epoxy resin, placed in molds with epoxy 
resin, and polymerized at 60° C for 2–3 days. The 50-nm ultrathin sections were cut 
using an Ultracut E microtome by Riechert-Jung. The USA300 LAC strains were imaged 
on a JEOL 2100 200 KeV TEM, while Mu50 strains were imaged on a JEOL 1230 120 
KeV TEM. Cell wall thicknesses were measured using the biological image analysis 
platform Fiji ImageJ (116) at a final magnification of ×60,000. At least fifteen cells of 
each strain, with approximately medial cuts, were measured, and the results were 
expressed as the mean ± standard error (SE). 
3.3 Antibiotic-susceptibility assay 
The antibiotic susceptibility of all strains was measured in triplicate by the broth 
microdilution method, per CLSI guidelines (117). MHB supplemented with 2% NaCl 
was used for all broth microdilution experiments. Antibiotic-containing wells were 
inoculated with 5 × 105 CFU/mL (118). After overnight incubation at 35°C, the wells 
were analyzed for visible bacterial growth, as indicated by turbidity. The lowest 
concentration of antibiotics that prevented bacterial growth was considered to be the 
minimum inhibitory concentration (MIC). 
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3.4 Growth curves and CFU count 
An aliquot of fresh bacterial culture was diluted to about 0.05 OD in 25 mL of 
fresh TSB in a 250-ml conical flask and grown at 37°C with shaking at 225 rpm. The 
OD600 was read at various time points. To analyze the growth of the msaABCR-operon 
mutants in the presence of lysozyme, 500 µg/mL lysozyme was added when the culture 
OD600 reached 1, and the OD600 was measured hourly for up to 8 hours. The population 
profile at 2-, 4- and 6-hour time points was determined by serially diluting culture 
aliquots to the appropriate dilution and plating them in TSA plates. Lysozyme 
(500 µg/mL) was added to the culture after 2 hours of growth for population profile 
determination (119). 
3.5. Lysis assays 
3.5.1 Lysozyme-induced lysis assay 
Lysozyme-induced lysis of S. aureus wild-type and msaABCR-mutant strains 
were measured after suspending the cells in PBS buffer, pH 7.4, containing lysozyme 
(350 μg/mL). Briefly, overnight cultures of S. aureus strains were pelleted, washed twice 
with ice-cold PBS buffer, and suspended in buffer containing 350 μg/mL of lysozyme. 
The initial OD600 nm was adjusted to 0.8, and the decrease in OD600 was measured at 
hourly intervals for 6 hours and finally at 24 hours, all at 37°C (120). 
3.5.2 Lysostaphin-susceptibility assay 
A lysostaphin-susceptibility assay was performed as described previously (121). 
Exponentially growing cultures of S. aureus were pelleted, washed once in lysostaphin 
buffer (50 mM Tris-HCl [pH 7.5]), and resuspended in fresh buffer to the original culture 
volume. Lysostaphin (Sigma-Aldrich) was added to each culture at a final concentration 
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of 0.5 μg/mL. The OD600 of each culture was read at the indicated time points and plotted 
as a percentage of the initial reading, which was set at 100% at 0 min. 
3.6 Peptidoglycan preparation and lysis assay 
Peptidoglycan without teichoic acid and acetyl groups was prepared as described 
previously with some modifications (122). Briefly, bacteria were grown overnight in 50 
mL of TSB, harvested by centrifugation, and washed twice with sodium acetate buffer 
(20 mM, pH 4.6). Cells were disrupted in the same buffer using glass beads. The 
resulting preparations were boiled in the presence of 2% (w/v) sodium dodecyl sulphate 
(SDS) for 45 min, followed by washing with water and buffer to remove the SDS. These 
cell wall preparations were then treated with RNAase, DNAase, and trypsin and then 
finally heated at 60°C with trichloroacetic acid (10% w/v) for 5 hours to remove teichoic 
acids. The cell wall preparations were washed 3 times with water to wash off TCA. 
Finally, O-acetyl groups were removed by alkaline treatment of the peptidoglycan (3 
hours in 80 mM NaOH at 37°C) (119). Peptidoglycan preparations were stored frozen at 
–85°C. For the lysis assay, peptidogycan preparations were thawed and suspended in 
PBS buffer containing 350 μg/mL of lysozyme. The initial OD600 was adjusted to around 
0.8, and the decrease in OD was measured at 30-min intervals over 2 hours at 37°C. 
3.7 Muropeptide analysis by HPLC 
For muropeptide analysis, 1 liter of TSB medium was inoculated with freshly 
grown culture and incubated to an OD600 of 0.05. The cultures were grown at 37°C to 
early exponential phase (OD600 of 0.7). The cells were cooled on ice and subsequently 
collected by centrifugation (18,000 x g for 10 min). Peptidoglycan was purified as 
previously described (123, 124). Briefly, the bacterial cell suspension was boiled in 4% 
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(w/v) SDS and washed several times with water. The cells were then transferred to a tube 
containing 0.1-mm glass beads (Biospec Products, Inc., Bartesville, OK) and lysed using 
a FastPrep instrument. Lysed cells were treated with DNase (10 g/ml), RNase (50 
g/ml), and trypsin (50 g/ml) and finally with 48% hydrofluoric acid to remove teichoic 
acid, thereby generating the purified peptidoglycan fraction. 
Muropeptides were prepared by digesting 5 mg of purified peptidoglycan with 25 
µg of mutanolysin (Sigma-Aldrich), reduced with sodium borohydride (Sigma-Aldrich), 
and then analyzed by reverse-phase HPLC using a Hypersil ODS column (Thermo 
Electron Corporation), as described previously (125). We used reverse-phase HPLC with 
a 3-µm particle size, 120-A pore size, octyldecyl silane hypersil (250×4.6 mm) C18 
column equipped with a 10×4-mm guard column made of the same material (Thermo 
Electron Corporation). The column temperature was kept at 52°C. We used a sodium 
phosphate/methanol buffer system without sodium azide. HPLC traces were recorded at 
206 nm, and the muropeptide profiles of three independently grown cultures was 
determined. For quantification purposes, the area of the muropeptide peaks was 
integrated and quantified using Bio-Rad ChromLab software and displayed as the 
percentage of the total (20 min-155 min) peak area. The average values with the standard 
error of the three experiments are shown in the result. 
3.8 RNA extraction, reverse transcription, and quantitative reverse-transcription 
PCR 
Required volume of cultures were treated with equal volumes of RNA protect 
bacterial reagent (Qiagen, Valencia, CA) for 5 min at room temperature. Treated cells 
were collected by centrifugation, and the total RNA was extracted as described 
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previously following manual provided with the Qiagen RNeasy kit (Qiagen) (109, 110). 
Extracted RNA quality and concentration was examined using a NanoDrop 
spectrophotometer (Thermo Scientific). CDNA were prepared from 1 μg of the total 
RNA using reverse transcription reaction using the iScript cDNA synthesis kit (Bio-Rad 
Laboratories, Hercules, CA) following the manufacturer’s instruction. qRT-PCR reaction 
mixture was prepared using SYBR Green supermix (Bio-Rad) and performed in biorad 
thermocycler. The relative gene expression was determined using calculation of delta CT 
value. We used gyrB as the internal housekeeping gene control for all our experiments 
(109, 110, 126). The data represent the results from three independent experiments. All 
the primers used for qRT-PCR are listed in Table 3.2. 
3.9 Membrane purification and PBP detection 
PBPs were detected using fluorography from membranes prepared from wild-type 
and msaABCR-mutant strains following the method described by Ozden et al. and 
Dhritiman et al. (109, 127), with some modifications. Briefly, cells were grown to 
exponential phase (OD600 ~ 0.7), harvested, washed once with wash buffer (50 mM Tris, 
150 mM NaCl, 5 mM MgCl2 [pH 7.5]), and resuspended in the same buffer with 0.5 mM 
phenylmethylsulfonyl fluoride and 10 mM β-mercaptoethanol. Cells were labelled with 5 
µg/mL Bocillin-FL (Thermo Fisher Scientific) for 10 min, then treated with lysostaphin 
(100 μg/ml), DNase (20 μg/ml), and RNase (10 μg/ml) for 30 min at 37°C, followed by 
sonication. Cell and membrane fragments were harvested by centrifugation at 110,000 
× g for 40 min at 4°C. Membranes were solubilized with 2% Triton X-100. Protein 
concentrations were measured using the bicinchoninic acid (BCA) protein assay kit 
(Pierce), and 20 μg of membrane proteins were mixed with 4× SDS-PAGE sample buffer 
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and boiled for 5 min. Samples were separated on a 4–20% gradient gel, and Bocillin-FL-
labeled proteins were detected with Alexa Fluor 488 using a Bio-Rad Versa Doc system. 
The gel images were analyzed and quantified using Image Lab software. 
3.10 Zymographic analysis 
Zymographic analyses were performed as described previously (128, 129). Cells 
were grown until exponential growth phase and harvested as described above. The cell 
pellet was suspended in SDS sample buffer and boiled for 20 min. The boiled samples 
were centrifuged at 17,000 × g, and volumes of supernatant normalized to the OD of the 
initial culture were loaded onto 12% SDS-PAGE gels containing 3% (w/v) heat-killed S. 
aureus RN4220 cells. The gels were washed twice in nanopure water and incubated in 
renaturation buffer (0.1% Triton X-100, 10 mM CaCl2, 10 mM MgCl2, 50 mM Tris–HCl, 
pH 7.5) at 37°C with gentle agitation. The gels were subsequently stained with 0.1% 
methylene blue. 
3.11 Wall teichoic acid (WTA) isolation, purification, and quantification 
WTA was specifically isolated as previously described (130, 131). Bacteria were 
grown overnight in 50 mL of TSB, harvested by centrifugation, and washed twice with 
sodium acetate buffer (20 mM, pH 4.6). Cells were disrupted in the same buffer using 
glass beads (with a Fast Prep instrument). 
To isolate WTA, 500-μL aliquots of crude cell extracts from wild type, mutant, 
and complementation strains having the same OD were diluted 4-fold in sodium acetate 
buffer containing 2% SDS, sonicated for 15 min, and then vigorously shaken for 1 hour 
at 60°C. The cell walls were sedimented by centrifugation, subjected to repeated 
washings with sodium acetate buffer to remove the SDS, and finally resuspended in 1 mL 
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of sodium acetate buffer. WTA was extracted by diluting 250 μL of purified cell walls 4-
fold in 5% trichloroacetic acid and incubating at 60°C for 4 hours. The peptidoglycan 
was removed by centrifugation, and the WTA was quantified by determining its 
inorganic phosphate (Pi) content as described in Covas et al. (131).  
3.12 Generation of Transposon Mutants  
The transposon mutants used in this study were created as following previously 
described method (101, 102). Briefly, JE2 strain, a plasmid-cured derivative of LAC, 
with transposon mutation of the corresponding genes was obtained from the Network on 
Antimicrobial Resistance in the S. aureus (NARSA) collection (Bei Resources). The 
cidC:Tn, cidR:Tn, msaABCR/cidC:Tn, and msaABCR/cidC:Tn mutant were created by 
transduction of the bursa aurealis transposon cidC and cidR mutants in JE2 strain to 
USA300 LAC wild type and msaABCR mutant strains using bacteriophage Φ11. The 
transduction of the mutation into the recipient strains was verified by PCR amplification 
of gene using primers binding to the beginning and end of the open reading frame (ORF) 
of the corresponding genes (Table 3.2), as previously described (101, 102, 132). 
3.13 Biofilm assays  
To perform the biofilm assays, we followed the original protocol outlined by 
Sambanthamoorthy et al. with modifications added by Sahukhal and Elasri (28, 31). First, 
we pre-coated each well of the microtiter plates with 20% human plasma and then 
allowed the plates overnight incubation at 4°C. Next, 2 mL of starter culture in biofilm 
medium was added to each well. The biofilm media prepared for this assay was made by 
mixing TSB with 3% NaCl and 0.25% glucose. For the excess glucose conditions, we 
added an additional 0.5% glucose to the appropriate wells. We also added vancomycin 
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(0.2 g/mL) when necessary. The microtiter plates were allowed to incubate at 37°C for 
24 hours with continuous shaking at 150 rpm. After 24 hours, we washed each well with 
sterile phosphate-buffered saline (PBS), stained the resulting biofilms with crystal violet 
dye, and eluted with 5% acetic acid. To measure the amount of biofilm, we used a 
spectrophotometer to quantitate absorbance at 595 nm. The assays were performed in 
experimental duplicates for USA300 LAC (wild type), msaABCR mutant, and 
complementation strains. The biofilm assays were performed three times. Biofilm 
formation values were calculated as the percent activity relative to USA300 LAC (wild 
type), which was set as 100%. Next, the mean values and standard deviations of each 
growth condition were calculated.  
3.14 Stationary phase survival assay 
To figure out the effects of excess glucose on cell death, the survival of different 
strains was monitored for 5 days (120 hours). Wild type, msaABCR mutant, and 
complementation strains of USA300 LAC were grown aerobically in TSB with excess 
glucose (35 mM glucose) and, when necessary, supplemented with 
morpholinepropanesulfonic acid (MOPS) buffer (50 mM), pH 7.3. Cultures were 
incubated at 37°C for 120 hours with continuous shaking at 220 rpm, with samples 
collected at 24-hour intervals. For some strains, survival was measured after 72 hours of 
growth counting colony-forming units (CFUs) in each sample. To measure the CFUs in 
each sample, cultures were serially diluted up to the appropriate dilutions, and 100-L 
aliquots were plated in TSA plates. The TSA plates were then incubated overnight at 
37°C. To verify the consistency of these results, the cell death assays for each sample 
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were performed in triplicate and repeated at least three times. The CFUs for each sample 
were averaged to obtain the mean values, and the standard deviation was calculated.  
3.15 Metabolite analyses 
For metabolite concentration measurement, different strains were grown at 37°C 
and 225 rpm in flasks with TSB plus 35 mM glucose. Metabolite profiles were measured 
from culture supernatants harvested at indicated times and indicated growth conditions 
after incubation. Glucose and acetate concentration were determined with the help of 
commercial kits (R-Biopharm, Marshall, MI) following manufacturer's instructions.  
Acetoin assays were performed as previously described (133). Briefly, 300 μL of 
supernatant was mixed with 210 μL of 0.5% creatine, 300 μL of 5% α-napthol, and 300 
μL of 40% KOH. Each sample was incubated for 15–30 minutes. The OD560 was 
measured and used to determine the concentration of acetoin. 
3.16 Expression and purification of MsaB 
MsaB protein with 6×His tag attached at C-terminal end (MsaBhis) were cloned 
with the inducible plasmid pCN51 construct. MsaBhis-PCN51 construct was first 
transformed into E. coli strain DH5α and transduced into RN4220 competent cells. The 
expression vector was then moved to the USA300 LAC msaABCR mutant strain through 
generalized transduction method utilizing bacteriophage ϕ11, as described in previous 
studies (101).  Protein expression was induced by adding 20 μM cadmium chloride 
(CdCl2) to msaABCR mutant cells with msaBhis expression vector at exponential phase 
and incubating further 4 hours with shaking. The cells were then collected using 
centrifugation, washed with PBS, resuspended in lysis buffer (PBS (pH 7.4) with a 
protease inhibitor cocktail), and lysed in Fast prep using bead beating followed by 
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sonication. The clear cell lysate was collected after centrifugation at 10,000×g for 30 min 
to remove the cell debris. Nickel column (HisPur Ni-nitrilotriacetic acid [Ni-NTA] resin; 
Thermo Scientific) was used for purification of the 6×His–MsaB fusion protein from the 
clear lysate. 
3.17 Electrophoretic mobility shift assay (EMSA)  
Binding activity of MsaB with cidR gene promoter was determined using 
electrophoretic mobility shift, as described previously (101). Briefly, the 5′-biotinylated 
PcidR-EMSA forward/reverse primers were used to amplify the DNA from the upstream 
promoter region of cidR gene (Table 3.2). 250 μL of the PCR product was loaded onto a 
2% agarose gel, separated by electrophoresis and corresponding PcidR fragment is 
purified from gel using Wizard SV gel and PCR cleanup system (Promega). DNA 
concentration and quality of the purified product was accessed using for a NanoDrop 
spectrophotometer (Thermo Scientific). To study binding activity of MsaB on 
the CidABC & alsSD promoters,  5′-biotinylated duplex oligonucleotide sequence of 
promoter region of these genes were used as in previous studies in the (75). LightShift 
Chemiluminescent EMSA kit (Pierce) following manufacturer’s protocol, was used for 
EMSA experiments. Binding reaction mixture, 20 μL contained ultrapure water, 1X 
binding buffer, 50 ng μL− 1 poly(dI-dC), 2.5% (vol/vol) glycerol, 5 mM MgCl2, and 5′-
biotin-labeled DNA probe. Increasing concentrations of MsaBhis protein and unlabeled 
specific probe, when required, were added. The reaction mixture was incubated at room 
temperature for 20 min and separated in electrophoresis at 100 V for 1 h in a pre-run 5% 
Tris-borate-EDTA (TBE) gel. The sample in the gel were then transferred to a nylon 
membrane (1 h in the cold), cross-linked in UV crosslinker, and processed for the 
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detection. The blot in were developed and visualized using the detection module in kit 
following manufacturer’s protocol and imaged with the ChemiDoc system (Bio-Rad). 
3.18 Western blotting of MsaBhis 
To quantify the amount of MsaBhis production under different growth conditions, 
western blotting was performed with protein sample obtained from whole-cell lysates as 
described previously (103). The USA300 LAC msaABhisCR complementation cells were 
grown in the presence of 2% pyruvate-supplemented TSB without glucose, TSB with 35 
mM glucose, and TSB without glucose. 5 h grown cells were pelleted by centrifugation, 
washed with PBS, resuspended in lysis buffer (PBS with a protease inhibitor) and lysed 
in Fast prep with glass beads. The clear supernatants were obtained after centrifugation of 
whole cell lysate removing debris. Proteins from different growth conditions were 
quantified by BCA method using the Pierce BCA protein assay kit (Life Technologies); 
and 25 μg of proteins were separated in SDS-polyacrylamide gel. Proteins in the gel were 
transferred to polyvinylidene difluoride (PVDF) membrane using blotting and blocked 
with 5% nonfat skimmed milk, MsaBhis was detected in blot with an anti-His antibody 
and a peroxidase-conjugated secondary antibody.  
3.19 Murein hydrolase assay 
Starter culture was incubated for 16 h at 37°C and 250 rpm. The extracellular 
exoproteins were collected from the culture supernatants. Extracted proteins were 
concentrated approximately ten-fold using a Centricon‐3 concentrator (Millipore, 
Bedford, MA). Protein concentrations of each exoproteins for each strain were 
determined using the BCA protein assay kit (Life Technologies), according to the 
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manufacturer's recommendations. Quantitative cell wall hydrolysis assay were performed 
as described previously (73). 
3.20 Statistical analysis 
All statistical analyses to test significant differences in this study were done using 
OriginPro software (Origin Lab, Northampton, MA). A statistical significance level of 
p<0.05 was set as the cutoff value in performing statistical analyses. Student’s t-test 
(unpaired) or one-way analysis of variance (ANOVA) followed by Tukey’s multiple 
comparison test were used to compare the results for wild type with that of mutants 




Table 3.1 Strains used in the study 
Strains or plasmids Relevant characteristics Reference/ source 
E. coli DH5α F− ϕ80lacZΔM15 recA1 Life Technologies 
RN4220 Restriction-deficient laboratory strain NARSA 
USA300 LAC CA-MRSA USA300 strain Dr. Shaw 
USA300 LAC ∆msaABCR USA300 LAC msaABCR-deletion 
mutant 
Sahukhal & Elasri 
USA300 LAC ∆msaABCR. 
pCN34 msaABCR 
(pCN34–msaABCR operon) 
complementation into USA300 LAC 
msaABCR-deletion mutant 
Sahukhal & Elasri 
USA300 LAC msaABhisCR 
complementation 
(pCN34–msaABhisCR operon) 
complementation with His-tagged msaB 
into USA300 LAC ∆msaABCR. 
This study 
Mu50 VISA, MRSA, mecA+ Ermr, ST5   ATCC 




complementation in Mu50 msaABCR-
deletion mutant 
  This study 
MOE 458 USA300 LAC proteases deletion mutant Dr. Mark Smeltzer 
MOE 466 USA300 LAC ∆msaABCR & proteases 
mutant 




Table 3.1 Continued   
Strains or plasmids Relevant characteristics Reference/ source 
USA300 LAC CidC:Tn USA300 LAC cidC transposon mutant This study 
USA300 LAC 
∆msaABCR/CidC:Tn 
USA300 LAC ∆msaABCR and cidC 
transposon mutant 
This study 
USA300 LAC CidR:Tn USA300 LAC cidR transposon mutant This study 
USA300 LAC 
∆msaABCR/CidR:Tn 






Table 3.2 List of primers used in this study. 
  Primer Sequence (5′ to 3′) Reference 
Primers for real-time PCR 
RT gyrA F GCCGTCAGTCTTACCTGCTC (110) 
RT gyrA R AATAACGACACGCACACCAG (110) 
RT glmU F TACAGTTAACTATGATGGTGAAAATAA This study 
RT glmU R AATTGTTACAGGTGCTACTAAATTAAC This study 
RT murA F TGTGCACCTTGCAATTGACT This study 
RT murA R CCGTTTTATGCATGTTGCAG This study 
RT murB F CATAAGCGCCAGCATTCATA This study 
RT murB R CTCACGTGTTGCTCGTGATT This study 
RT murD F AGCCTACAGATTATTTAGTTACAGAGT This study 
RT murD R TAAATGTTAGTAATTATAGCAATGTGTG This study 
RT fmhB (femX) F GTTCAAAACTATTTAATAACTCATCATC This study 
RT fmhB (femX) R ATTTAAAGAAGGTTTATCAAAAGACTAC This study 
RT femA F CGCAAACTGTTGGCCACTAT This study 
RT femA R AAGCAAGCTGCAATGACCTC This study 
RT femB F GCGAGAAAAATGATGCCCTA This study 
RT femB R TACGCCCATCCATCGTACTT This study 
RT mecA F CGACTTCACATCTATTAGGTTAT This study 




Table 3.2 Continued 
  Primer Sequence (5′ to 3′) Reference 
RT ppb1 F GGATTAAATGTTGGTCGCTGA This study 
RT pbp1 R TTATTTGCGGTTGTCATGGA This study 
RT pbp2 F ATGTGAAGAGAACGATTATTAAGATTAT This study 
RT pbp2 R AATAAGCAAACAATAAGATACCTAGTAA This study 
RT pbp3 F GTGGACCAACCTCATCTTTA This study 
RT pbp3 R CGGGAGACCCTTATTATTCT This study 
RT pbp4 F CCGTTGGATTGACGAAATGT (109) 
RT pbp4 R ACCAGCGATTTCGTTGATTT (109) 
RT tarO F AATTGCCGCTGCCTTAGTAGTT This study 
RT tarO R TGTACCCATTGGCAACGAAA This study 
RT tarA F CTTACAGTAGATGGAGAGATACAGTTAT This study 
RT tarA R AGATGTGTTACTCAAAAAGTTATAGAAG This study 
RT atlA F ATAACCGCACTGGTTGGGTA This study 
RT atlA R TTGGCAGCTGATGTAGTTGG This study 
RT lytM F TCAAAATGGTGGATCAGCAA (110) 
RT lytM R CACCACCGTGATATTGTCCA (110) 
RT sle 1 F ACATGGGGTCAATGTACATATCATG (110) 
RT sle 1 R CGTTATCCCAGTTATTAGCATTCCA (110) 
RT lytN F TTTGGTGGAGGATATGGTCA (110) 
RT lytN R GCCATCCACCATTATTCCAG (110) 
RT lytH F ACCTCCATGACCAGGATCAA (110) 
RT lytH R GATAGCTGGATGGCACACAA  (110) 
RT lytX F TCCCAACCATGCTTTTTAGC (110) 




Table 3.2 Continued 
  Primer Sequence (5′ to 3′) Reference 
RT lytY F GATGTTGCGCAGGATTTTCT (110) 
RT lytY R CGATTATTGGTGGTGCAAAG (110) 
RT lytZ F CCGAAAATATCCAAGCACGA (110) 
RT lytZ R TCCGATTTCCATGTTGGTTT (110) 
RT oatA F TATTAAATAACCTGAAATAACGAAGAAT This study 
RT oatA R AGTTATAGGAATCATTATTTATCACTTG This study 
RT gyrB F GGTGCTGGGCAAATACAAGT (110) 
RT gyrB R TCCCACACTAAATGGTGCAA (110)  
RT ackA F ATGTTATCGTATTTACAGCAGG This study 
RT ackA R CCAGTAAACACCCATAAATTCT This study 
RT pta F GATCCAAAAGTTGCAATGTTAA This study 
RT pta R TTTTGTTGTGCTAATTTGACAG This study 
RT acsA F TATATTTTGCGTTGTTAGGTGT This study 
RT acsA R AGCTTCACTGTTCTCTAATCTA This study 
RT pykA F AGTACAGATGCATTGTTAAACA This study 
RT pykA R GTACACCAGCAGTAATAATGAT This study 
RT cidA F GGGTAGAAGACGGTGCAAAC This study 
RT cidA R TTTAGCGTAATTTCGGAAGCA This study 
RT cidC F TATTTGTCCTAACGACTTATTAACTG This study 
RT cidC R GTCTTTATATTTTGGTGATACTACTGTT This study 
RT cidR F CGCCCTTATTTGATAGAAGTAAAA This study 




Table 3.2 Continued 
  Primer Sequence (5′ to 3′) Reference 
RT alsS F TTGGATGGCACGTAATTTCA This study 
RT alsS R GCCAGCAACGGATACAACTT This study 
RT lrgA F GCATCAAAACCAGCACACTTT This study 
RT lrgA R TGATGCAGGCATAGGAATTG This study 
RT msaC F CCAGAAATCATTATCGGAATCACTA (100) 
RT msaC R TTAGTTTTCGGTGTATTATCTGCAA (100) 
RT msaB F TTTATCGAAGTTGAAGGAGAAAATG (100) 
RT msaB R ACTCAACAGCTTGACCTTCTTCTAA (100) 
RT msaA F TCGATAACTATGTCACAGGCAAATA (100) 
RT msaA R TTGTAAATCCTCTTCACAATCTTCG (100) 







PcidR-EMSA F Biotin-ACTTGAGCCATTAATATAATACCA This study 
PcidR-EMSA R TCCACTAACATCATCCTAACTATT-Biotin This study 
Primer for Transposon mutant verification 
CidC Tn F GACAGAAAGGGAGGCTATTA This study 
CidC Tn R CATTACCAGTAACACGCAAG This study 
CidR Tn F CTCAATACCTCACCTCGATT This study 
CidR Tn R CCAAACAACACCTAATTCCC This study 
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CHAPTER IV – ROLE OF THE MSAABCR OPERON IN CELL WALL 
BIOSYNTHESIS, AUTOLYSIS, INTEGRITY, AND ANTIBIOTIC RESISTANCE IN 
STAPHYLOCOCCUS AUREUS 
4.1 RESULTS: 
4.1.1 Deletion of the msaABCR operon leads to increased susceptibility to 
antimicrobials that target the cell wall  
To study cell wall defects in the msaABCR-deletion mutant, we first examined the 
cell structure and cell wall thickness of msaABCR operon mutants using transmission 
electron microscopy in both the highly virulent community-acquired MRSA strain, 
USA300 LAC, and the clinical vancomycin intermediate-resistance (VISA) isolate strain, 
Mu50. Mutants of USA300 LAC and Mu50 showed significant decreases (about 45%) in 
cell wall thickness, with a smoother texture relative to their respective wild-type strains 
(Fig. 4.1 A–C). These results suggest that the msaABCR operon plays an important role 
in cell wall synthesis and maintenance in both MRSA and VISA strains. We then 
investigated the impact of msaABCR operon deletion on resistance to cell wall-active 
antibiotics. We measured the susceptibility of the msaABCR-deletion mutants to cell 
wall-targeting antibiotics (vancomycin, methicillin, oxacillin, cloxacillin, cefoxitin, 
bacitracin, and fosfomycin) relative to wild type by using a microdilution assay to 
determine the minimum inhibitory concentration (MIC, Table 4.1). We found that 
deletion of the msaABCR operon led to an increase in susceptibility to antibiotics that 
target cell wall synthesis and crosslinking (vancomycin [binding to lipid II], methicillin, 
cefoxitin, cloxacillin, and oxacillin) in both the USA300 LAC and Mu50 strains. In the 
USA300 LAC strain, the msaABCR-deletion mutant was more susceptible than wild type 
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to fosfomycin; however, this was not observed in the Mu50 strain. The increased 
susceptibility of msaABCR mutants to several cell wall-targeting antimicrobials suggests 
that the integrity of the mutant bacterium cell wall is compromised. 
 
Figure 4. 1 The msaABCR operon regulates cell wall morphology. Transmission electron 
micrographs of cells of the wild-type and msaABCR operon-deletion mutant in the Mu50 (A) and USA300 LAC (B) strains. Cell wall 







Table 4. 1 Minimum inhibitory concentration (MIC) for different cell wall-targeting antimicrobials in msaABCR-mutant Mu50 
(VISA) and USA300 LAC (MRSA) strains. 
Antibiotic 
tested 
Minimum Inhibitory Concentration (µg/mL) 
 




Vancomycin 6.5 1.65 3.25 0.825 0.412 0.825 
Binds to D-Ala D-Ala and prevents peptidoglycan 
crosslinking 
Methicillin 1000 500 1000 25 12.5 25 Inhibits PBPs and peptidoglycan crosslinking 
Cefoxitin 250 125 250 25 12.5 25 Inhibits PBPs and peptidoglycan crosslinking (PBP4) 
Cloxacillin 500 62.5 500 1.56 0.195 0.781 Inhibits PBPs (Tpases) and peptidoglycan crosslinking 
Oxacillin 500 125 500 50 12.5 50 Inhibits PBPs (Tpases) and peptidoglycan crosslinking 
Fosfomycin >1000 >1000 >1000 50 25 50 
Inhibits bacterial cell wall biogenesis by inactivating the 
enzyme MurA 
Bacitracin 250 250 250 100 200 200 
Interferes with the dephosphorylation of bactoprenol, 
which transports the building blocks of the peptidoglycan 
bacterial cell wall outside of the inner membrane 
Lysostaphin 1.25 0.312 0.625 0.156 0.078 0.156 
Cleaves the crosslinking pentaglycine bridges in the cell 
wall peptidoglycan 
 




Figure 4. 2 msaABCR-mutant growth yield is lower than wild type in the presence 
of lysozyme. Growth curve in the presence of lysozyme. The starter cultures for all test strains were normalized to an OD600 of 
0.05 and incubated further until an OD600 reading of 1.0. The cultures were then treated with 500 µg/mL lysozyme, and the growth 
kinetics were measured by taking the OD600 reading every hour. A) Mu50 and B) USA300 LAC strain backgrounds and their 
respective msaABCR-mutant and complementation strains. These results represent the means of three independent experiments. Error 
bars represent the standard error (SE). Student’s t-test and one-way analysis of variance (ANOVA) were used to compare the results 
for the wild-types with their corresponding mutants (*p<0.05, **p<0.005, ***p<0.0005). (Source: G C et al. 2019, (106)) 
4.1.2 msaABCR-deletion mutants are more susceptible to cell wall-active enzymes 
We investigated the nature of the cell wall perturbation in the msaABCR-deletion 
mutant by measuring its growth kinetics in the presence of lysozyme, a hydrolase that 
catalyzes the hydrolysis of 1,4-beta-linkages in the glycan chain in peptidoglycan. By 
measuring OD600, we monitored the effect of lysozyme (500 µg/mL) on msaABCR-
mutant cultures and compared them with their respective wild-type and complementation 
counterparts in both Mu50 (Fig. 4.2A) and USA300 LAC (Fig. 4.2B) strains. Lysozyme 
was added when the starter culture reached an OD600 of 1 in tryptic soy broth (TSB). We 
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observed that the msaABCR-deletion mutant cells were lysed significantly faster than 
their respective wild-type and complementation counterparts (Fig. 4.2).  
In addition, population analysis showed a >2–3-fold reduction in the msaABCR-
mutant population after 6 hours (4 hours post addition of 500 µg/mL lysozyme treatment) 
compared with their respective wild-type counterparts (Fig. 4.3 A, B). We also measured 
the rate of cell lysis in the presence of lysozyme. For this, we harvested exponentially 
growing cells and measured whole-cell lysis as the percentage of the initial OD600 at 
different time points over 24 hours in the presence of 350 µg/mL lysozyme.  
 
Figure 4. 3 msaABCR-mutant S. aureus is lysed with lysozyme at a faster rate 
than wild type. Population profile at different time points, when 500 µg/mL lysozyme was added to cultures of the A) Mu50 
and B) USA300 LAC strain backgrounds and their respective msaABCR-mutant and complementation strains after 2 hours of growth 
of the starter culture. These results represent the means of three independent experiments performed in triplicate. Error bars represent 
the SE. Student’s t-test and one-way ANOVA were used to compare the results for the wild-types with their corresponding mutants 
(*p<0.05, **p<0.005, ***p<0.0005). (Source: G C et al. 2019, (106)) 
We observed that the msaABCR-deletion mutants lysed at a significantly higher 
rate than their respective wild-type and complementation counterparts in both Mu50 (Fig. 






Figure 4. 4 msaABCR-mutant cells are lysed at a faster rate than wild type in the 
presence of lysozyme. Lysozyme-induced whole-cell lysis. S. aureus cells were suspended in PBS and digested with 350 
μg/mL lysozyme. Cell lysis was measured as a decrease in OD600 in A) Mu50 and B) USA300 LAC strain backgrounds and in their 
respective msaABCR-mutant and complementation strains. These results represent the means of three independent experiments. Error 
bars represent the SE. Student’s t-test and one-way ANOVA were used to compare the results for the wild-types with their 
corresponding mutants (*p<0.05, **p<0.005, ***p<0.0005). (Source: G C et al. 2019, (106)) 
We then measured the susceptibility of msaABCR-mutant cells to a second cell 
wall-lytic enzyme, lysostaphin, which hydrolyzes the pentaglycine chain in 
peptidoglycan. We found that deletion of the msaABCR operon led to an increase in 
susceptibility to lysostaphin in both the USA300 LAC and Mu50 strains (Table 4.1).  We 
then measured cell lysis in the presence of lysostaphin. In this assay we harvested 
exponentially growing cells and measured whole-cell lysis as a percentage of the initial 
OD600 over 1 hour at regular 15 minutes intervals in the presence of 0.5 μg/mL 
lysostaphin. However, we observed a significant increase in whole-cell lysis in the Mu50 
strain msaABCR mutant (Fig. 4.5 A), but not in the USA300 LAC strain msaABCR 
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mutant (Fig. 4.5 B). Increased lysostaphin susceptibility in the msaABCR mutant in the 
Mu50 background indicates a defect in the mutant cell wall that may be due to a 
reduction in cell wall thickness and/or a reduction in cell wall crosslinking.  
 
 
Figure 4. 5 The msaABCR mutant of the Mu50 strain is lysed with lysostaphin at a 
faster rate than wild type. Lysostaphin lysis assay.  S. aureus wild-type, msaABCR-mutant, and complementation strains 
in the A) Mu50 and B) USA300 LAC strain backgrounds were grown to an OD of 1 at 37°C in TSB medium. Bacteria were harvested 
by centrifugation, washed twice with Tris buffer, and suspended to an initial OD600 of ∼1. Lysostaphin lysis assays were performed 
with 0.5 μg/mL lysostaphin, and lysis was measured as a decline in OD600 over time. These results represent the means of three 
independent experiments. Error bars represent the SE. Student’s t-test and one-way ANOVA were used to compare the results of the 
wild-types with their corresponding mutants (*p<0.05, **p<0.005, ***p<0.0005). (Source: G C et al. 2019, (106)) 
 
Previous studies have shown that the increased lysozyme sensitivity of S. aureus 
peptidoglycan is dependent on its degree of O-acetylation, teichoic acid content, and/or 
crosslinking (37, 119, 120). In order to evaluate which of these three factors contributes 
to lysozyme sensitivity in the mutants, we measured the expression of the oatA gene, 
which is involved in O-acetylation of peptidoglycan, in the msaABCR mutants relative to 
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their wild-type counterparts using quantitative real-time PCR (Table 4.2). Our results 
showed that both Mu50 and USA300 LAC wild-types and the msaABCR-deletion 
mutants have similar expression of the oatA gene. This result shows that lysozyme 
sensitivity in the mutants is not due to O-acetylation. In addition, we treated 
peptidoglycan preparations from all test strains with 10% TCA and 80 mM NaOH to 
remove teichoic acid and O-acetyl groups, as described in Materials and Methods. These 
peptidoglycan preparations (0.5 mg/mL) were then resuspended in 80 mM sodium 
phosphate-buffered saline and digested with 350 μg/mL lysozyme. We observed that the 
peptidoglycan preparation from msaABCR mutants lysed at a faster rate than the 
respective wild-type cell walls in both Mu50 (Fig. 4.6 A) and USA300 LAC (Fig. 4.6 B) 
strains. These experiments show that the increased lysis rate of the mutant cell wall is 
mainly due to reduced crosslinking and is not related to O-acetylation. We further 
investigated the contribution of teichoic acid content to the mutant phenotype in the last 
section of Results. 
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Figure 4. 6 msaABCR-mutant peptidoglycans are lysed in the presence of 
lysozyme at a faster rate than wild type. Digestion of peptidoglycan devoid of teichoic acid and acetyl groups with 
lysozyme. Peptidoglycan was suspended in 80 mM sodium phosphate-buffered saline (0.5 mg/mL) and digested with 350 μg/mL 
lysozyme. Lysis of peptidoglycan was measured as a decrease in OD600 in the A) Mu50 and B) USA300 LAC strain backgrounds and 
their respective msaABCR-mutant and complementation strains. These results represent the means of three independent experiments. 
Error bars represent the SE. Student’s t-test and one-way ANOVA were used to compare the results for the wild-types with their 
respective mutants (*p<0.05, **p<0.005, ***p<0.0005). (Source: G C et al. 2019, (106)) 
4.1.3 The msaABCR operon plays a role in cell wall crosslinking 
To gain a deeper insight into peptidoglycan composition, we purified 
peptidoglycan from the Mu50 and USA300 LAC strains and their respective msaABCR-
deletion mutants to determine their muropeptide composition. We digested the purified 
peptidoglycan with mutanolysin and analyzed the muropeptide composition using HPLC. 
The HPLC profiles of the mutants from both strains showed a marked difference in 
peptidoglycan composition relative to wild type (Fig. 4.7 and Fig. 4.8). We observed a 
significant reduction in the amount of oligomeric muropeptide with a retention time >104 
min, which corresponds to those oligomers greater than or equal to 9-mers in both 
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msaABCR mutants relative to their corresponding wild-type counterparts. Furthermore, 
we observed differences in the relative abundance of the monomeric peaks that elute 
between 19 min and 54 min between mutants and wild types. Specifically, the 
monomeric fraction was significantly higher in the msaABCR mutants relative to wild 
type (Fig. 4.7 and 4.8). As mutanolysin cleaves glycan chains in peptidoglycan, digestion 
of highly crosslinked peptidoglycan by mutanolysin produces more highly crosslinked 
muropeptides than less highly crosslinked peptidoglycan. Thus, a decreased relative 
abundance of oligomeric muropeptides and a concomitant increased abundance of 
monomeric muropeptides from digestion of msaABCR-mutant peptidoglycan with 
mutanolysin demonstrate that the msaABCR mutants have cell walls with reduced 
crosslinking in both the VISA Mu50 and MRSA USA300 LAC strains relative to their 




Figure 4. 7 msaABCR-mutant peptidoglycan is less cross linked than wild type. 
(A–C) HPLC chromatograms of mutanolysin-digested peptidoglycan purified from the 
indicated strains in the Mu50 strain background. The peaks were identified according to de Jonge et al. 
Representative results of three individual experiments are shown. D. Muropeptide composition expressed as a percentage of the total 
area under the curve for each strain. The figure shows percentages indicating the relative abundances of monomers, dimers, trimers to 
8-mers, and higher oligomers in each strain. These results represent the means of three independent experiments. Error bars represent 
the SE. Student’s t-test and one-way ANOVA were used to compare the results of the wild-type to mutants (*p<0.05, **p<0.005, 




Figure 4. 8 msaABCR-mutant peptidoglycan is less cross linked than wild type. 
(A–C) HPLC chromatograms of mutanolysin-digested peptidoglycan purified from the 
indicated strains in the USA300 LAC strain background. The peaks were identified according to de Jonge 
et al. Representative results of three individual experiments are shown. D. Muropeptide composition expressed as a percentage of the 
total area under the curve for each strain. The figure shows percentages indicating the relative abundances of monomers, dimers, 
trimers to 8-mers, and higher oligomers in each strain. These results represent the means of three independent experiments. Error bars 
represent the SE. Student’s t-test and one-way ANOVA were used to compare the results for wild-type with its deletion mutant 
(*p<0.05, **p <0.005, ***p<0.0005). (Source: G C et al. 2019, (106)) 




Several studies have shown that many factors affect crosslinking within the 
staphylococcal cell wall. Reduction in cell wall crosslinking may be due to a defect in the 
pentapeptide chains, decreased activities of penicillin-binding proteins (PBPs) (11-16), 
defects in pentaglycine bridges (10), and/or a decrease in peptidoglycan teichoic acid 
content (9). To identify the cause of the decreased crosslinking and decreased cell wall 
thickness in msaABCR mutants, we first measured the relative expression of genes 
involved in early cell wall synthesis, including pentapeptide- and pentaglycine- synthesis 
genes as well as peptidoglycan-crosslinking genes (PBPs), using quantitative real-time 
PCR (Table 2).  
Table 4. 2 Expression of cell wall biosynthesis and hydrolase genes in the msaABCR 
mutant relative to their expression in wild-type.  
 Mu50 USA300 LAC 
Gene Mean fold change ± SE Mean fold change ± SE 
glmU –2.77 ± 0.09 –1.19 ± 0.06 
murA –3.49 ± 0.18 –2.5 ± 0.38 
murB –1.29 ± 0.14 –1.48 ± 0.01 
murD –2.74 ± 0.03 1.47 ± 0.19 
fmhB(femX) 1.20 ± 0.04 1.42 ± 0.20 
femA –1.15 ± 0.03 1.04 ± 0.02 
femB –1.19 ± 0.02 –1.12 ± 0.04 
oatA 1.28 ± 0.16 –1.49 ± 0.13 
mecA –1.63 ± 0.04 1.21 ± 0.04 
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Table 4. 3 Continued 
Gene 
Mu50 USA300 LAC 
Mean fold change ± SE 
Mean fold change ± 
SE 
Pbp1 1.38± 0.05 1.21 ± 0.07 
pbp2 –1.1 ± 0.03 1.26 ± 0.12 
Pbp3 1.11±0.06 –1.12 ± 0.05 
pbp4 –1.34 ± 0.23 –1.21 ± 0.21 
atlA 2.49 ± 0.15 1.68 ± 0.13 
lytM 1.52 ± 0.08 1.59 ± 0.13 
Sle-1 1.05 ± 0.12 1.34 ± 0.07 
lytN 1.77 ± 0.23 –1.09 ± 0.09 
lytH –1.06 ± 0.2 1.3 ± 0.43 
LytX –1.06 ± 0.23 –1.06 ± 0.53 
lytY –1.01 ± 0.21 –1.07 ± 0.09 
LytZ 1.42 ± 0.24 1.37 ± 0.31 
tarO –1.56 ± 0.13 –1.67 ± 0.10 
tarA –1.82 ± 0.14 –1.59 ± 0.23 
 
These results represent the means of three independent experiments performed in triplicate. Genes up- or down-regulated by  or  
2.0-fold are shown in bold. (Source: G C et al. 2019, (106)) 
The results of qRT-PCR analysis indicate that reduction in the peptidoglycan 
crosslinking of msaABCR mutants is independent of the actions of penicillin-binding 
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proteins, since the mecA, pbp1, pbp2, pbp3, and pbp4 genes were not significantly 
differentially expressed (<2.0-fold change) in msaABCR mutants compared with wild-
type (Table 4.2). We also performed a fluorescent penicillin-binding assay with Bocillin-
FL to measure the levels of penicillin-binding protein. This assay showed that the 
msaABCR mutant and its complementation counterpart in the USA300 LAC and Mu50 
strains did not have significantly different levels of penicillin-binding proteins compared 
with wild type (Fig. 4.9), confirming that the crosslinking defect in the msaABCR mutant 
is independent of PBP activity. 
 
Figure 4. 9 Decreased crosslinking in msaABCR-mutant peptidoglycan is 
independent of PBPs. Fluorescent penicillin-binding assay with purified cell membranes from wild-type, its msaABCR 
mutant, and its complementation mutant in the USA300 LAC and Mu50 strain backgrounds. Gradient gel visualized with Alexa Fluor 
488. Representative results of three individual experiments are shown. (Source: G C et al. 2019, (106)) 
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The femXAB genes produce a family of nonribosomal peptidyltransferases 
involved in pentaglycine synthesis and cell wall crosslinking (134-136). Mutations 
in femAB reduce the amount of peptidoglycan crosslinking and the length of the 
pentaglycine chain, thus leading to a difference in tolerance to lysostaphin treatment 
(124, 135, 136). Our results showed that there are no significant changes in the 
expression level of these genes between the msaABCR mutant and wild-type in both 
strains (Table 4.2). Thus, the increased lysostaphin-induced lysis rate in the Mu50 
msaABCR mutant is not due to a difference in femXAB gene expression.  
In addition, we also measured the relative expression of several early 
peptidoglycan and teichoic acid biosynthesis genes (Table 4.2). We found that murA, 
glmU, and murD are significantly downregulated in the msaABCR-deletion mutant in 
Mu50; however, only murA was downregulated in the msaABCR mutant in USA300 
LAC. murA codes for UDP-N-acetylglucoseamine-1-carboxyvinyl-transferase-2, which 
catalyzes the conversion of UDP-GlcNAc to UDP-N-acetyl-3-(1-carboxyvinyl)-D-
glucosamine. Deletion of murA in S. aureus causes a significant reduction in 
peptidoglycan content (137). Since murA is involved in the rate-limiting steps of cell wall 
biosynthesis, the downregulation of this gene in the msaABCR mutant may contribute to 
decreased cell wall synthesis, leading to decreased cell wall thickness. glmU is a 
bifunctional protein that catalyzes the last two sequential reactions in the de novo 
biosynthetic pathway for UDP-N-acetylglucosamine (UDP-GlcNAc) (138). UDP-
GlcNAc is also a precursor for wall teichoic acid (WTA), along with peptidoglycan 
synthesis. Thus, decreased expression of glmU in the Mu50 msaABCR mutant may also 
contribute to decreased cell wall thickness. MurD (UDP-N-acetylmuramyl-L-alanine:D-
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glutamate ligase) is the bacterial D-glutamate-adding enzyme that catalyzes the 
attachment of D-glutamate to a cytoplasmic peptidoglycan precursor, UDP-N-
acetylmuramyl-L-alanine (138). This step is important for pentapeptide chain synthesis 
during cell wall biosynthesis. Thus, downregulation of murD in the Mu50 msaABCR 
mutant may also contribute to decreased cell wall synthesis rates and decreased 
crosslinking. Furthermore, we did not observe any significant changes in expression of 
teichoic acid synthesis genes (tarO, tarA) in the msaABCR mutants compared with wild 
type in either the Mu50 or USA300 LAC strains. Therefore, results show that decreases 
in peptidoglycan crosslinking of msaABCR mutants is independent of the actions of 
penicillin-binding proteins or any peptide chain synthesis defect. However, deletion of 
the msaABCR operon caused decreased expression of early biosynthetic genes in both the 
USA300 LAC and Mu50 strains, suggesting a lower peptidoglycan synthesis rate and/or 
lower peptidoglycan content in the mutant cell wall. 
4.1.5 The crosslinking defect in the msaABCR mutant is primarily due to increased 
protease activity 
We have previously reported that treatment of msaABCR-deletion mutants with 
Triton X-100 results in increased autolysis (109, 110) and have shown that the msaABCR 
operon negatively regulates the production of proteases, resulting in increased processing 
of murein hydrolases and thus affecting the rate of cell wall autolysis in the USA300 
LAC and Mu50 strains (38, 110). In this study we sought to investigate the potential role 
of protease activity in the crosslinking defect in the msaABCR mutants. Specifically, we 
hypothesized that the msaABCR operon plays a role in maintaining cell wall integrity via 




Figure 4. 10 Increased lysis in the msaABCR mutant is reversed to wild type 
levels when all proteases are deleted or inhibited in the mutant. Lysozyme-induced whole-cell lysis 
(A, B). S. aureus cells were suspended in PBS and digested with 350 μg/mL lysozyme. Lysis of A) Mu50 WT, its msaABCR mutant, 
and its msaABCR mutant grown in the presence of a protease-inhibitor cocktail and B) USA300 LAC WT, its msaABCR-deletion 
mutant, its all-protease-deletion mutant, and its msaABCR-deletion/all-protease-deletion double mutant was measured as a decrease in 
OD600. C. Lysostaphin lysis assay. Mu50 WT, its msaABCR mutant, and its msaABCR mutant grown in the presence of a protease-
inhibitor cocktail were grown to an OD of 1 at 37°C in TSB medium. Bacteria were harvested by centrifugation, washed twice with 
Tris buffer, and suspended to obtain an initial OD600 of ∼1. Lysostaphin lysis assays were performed with 0.5 μg/mL (A), and lysis 
was measured as a decline in OD600 over time. These results represent the means of three independent experiments. Error bars 
represent the SE. Student’s t-test and one-way ANOVA were used to compare the results of the wild-types with their mutants (*p 
<0.05, **p <0.005, ***p<0.0005). (Source: G C et al. 2019, (106)) 
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To test the potential role of protease activity in the crosslinking defect, we 
measured the lysozyme lysis rate in msaABCR-deletion/all-protease-knockout strains. In 
this study, we observed that the lysozyme-induced lysis phenotype of the msaABCR-
deletion mutant was restored to the wild-type level in the msaABCR-deletion/all-protease-
knockout strains in the USA300 LAC background (Fig. 4.10 B). Since we did not have 
these mutants in the Mu50 strain, we grew Mu50 cells in the presence of a protease 
inhibitor cocktail. When Mu50 msaABCR-mutant cells were grown in the presence of 
protease inhibitors, both lysozyme lysis (Fig. 4.10 A) and lysostaphin lysis (Fig. 4.10 C) 
rates were reversed to wild-type levels. These results suggest that increased protease 
activity is responsible for the crosslinking defect in the msaABCR mutants.  
To further confirm the role of the increased presence of proteases in the 
msaABCR-deletion mutant in contributing to a defect in cell wall crosslinking, we 
performed muropeptide composition analysis by HPLC on all strains, including all 
protease-knockout mutants and the msaABCR/protease double-deletion mutant in the 
USA300 LAC strain background. We observed that the relative composition of 
oligomeric muropeptides in these double mutants reverts to wild-type levels in the 
USA300 LAC strain background (Fig. 4.11). There was no significant difference in the 
relative amount of oligomeric muropeptides in USA300 LAC, USA300 LAC all-
protease-knockout strains, and msaABCR-deletion/all-protease-knockout strains. 
However, there was a significant reduction in the amount of oligomeric muropeptides, 
which represents the degree of crosslinking, with a retention time of >104 min in the 
msaABCR-deletion mutant, and this reverted back to the wild-type level in the msaABCR-
deletion/all-protease-knockout strains. This result further confirms that increased protease 
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activity contributes to defects in peptidoglycan crosslinking in msaABCR-deletion 
mutants in the USA300 LAC strain. 
 
Figure 4. 11 Crosslinking defect in the msaABCR-deletion mutant is due to 
increased protease activity. (A–D) HPLC chromatograms of mutanolysin-digested 
peptidoglycan purified from the indicated strains in the LAC strain background. The peaks 
were identified according to de Jonge et al. Representative results of three individual experiments are shown. E. Muropeptide 
composition expressed as a percentage of the total area under the curve for each strain. The figure shows percentages indicating the 
relative abundances of monomers, dimers, trimers to 8-mers, and higher oligomers in each strain. These results represent the means of 
three independent experiments. Error bars represent the SE. Student’s t-test and one-way ANOVA were used to compare the results 




4.1.6 The cell wall crosslinking defect in the msaABCR mutant is mediated by 
increased processing of the major autolysin, AtlA 
Our previous study showed that deletion of the msaABCR operon in the USA300 
LAC strain does not have any significant effect on expression of any of the known S. 
aureus murein hydrolase genes (atlA, lytM, lytN, lytX, lytY, lytZ, and sle1) (110). In this 
study, we measured the relative expression of these hydrolase genes in both the USA300 
LAC and Mu50 strains by qRT-PCR (Table 4.2). We confirmed similar results in the 
USA300 LAC strain background, as reported previously (110). However, atlA expression 
was upregulated by 2.49-fold in the Mu50 msaABCR mutant, while other genes were not 
differentially expressed.  
Peptidoglycan hydrolase cellular concentration, localization, and activity are 
believed to be intricately regulated and to play key roles in bacterial cell wall 
metabolism, daughter-cell separation, antibiotic-mediated cell lysis, and pathogenicity 
(103, 110). The major autolytic enzymes, AtlA and lytM, have been shown to undergo 
proteolytic processing to produce active hydrolytic enzymes and to determine their 
localization. AtlA is a bifunctional autolysin initially produced as a 138-kDa protein that 
subsequently undergoes proteolytic processing to generate the two major autolytic 
enzymes, 62-kDa N-acetylmuramyl-L-alanine amidase (AM) and 51-kDa N-
acetylglucosaminidase (GL) (18). Similarly, LytM (34 kDa), like other lysostaphin-type 
peptidases, undergoes proteolytic processing, producing smaller-sized active enzymes (19 
and 22 kDa) (41, 42). Previously, we showed that the msaABCR mutant produces more 
and differentially proteolytically processed cell wall-bound murein hydrolases during the 
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late-exponential growth phase and extracellular murein hydrolases during the stationary 
growth phase  in the USA300 LAC strain background in a protease-dependent manner 
(110). Since we saw crosslinking defects and increased autolysis in early exponential-
growth cells, we further investigated the role of the msaABCR operon in protease-
mediated processing of the cell wall-bound murein hydrolases during the early 
exponential growth phase. We performed a zymogram analysis of cell wall-bound murein 
hydrolases from early exponential-growth cells and measured their activity using S. 
aureus (RN4220) whole cells as substrates. The msaABCR-deletion mutant showed a 
significantly altered pattern of AM and GL activities relative to its wild-type and 
complementation counterparts in both Mu50 (Fig. 4.12 A) and USA300 LAC strains 
(Fig. 4.12 B). In the zymogram assay, the msaABCR-deletion mutants showed a 
significantly higher number of bands corresponding to amidases (AM) than did their 
wild-type counterparts. Also, the msaABCR mutants showed higher-intensity bands of 
glucosamidase (GL) activity compared with wild-type. Overall, these results confirm that 
the msaABCR mutants have increased processing and/or activity of murein hydrolases 






Figure 4. 12 Crosslinking defect in the msaABCR mutant may be mediated by 
increased processing of the major autolysin, AtlA, and increased activity. SDS-extracted, cell 
wall-bound murein hydrolase zymogram. (A) Cell wall-bound murein hydrolase zymogram of Mu50 WT, its msaABCR-deletion 
mutant, and its msaABCR complement. (B) Cell wall-bound murein hydrolase zymogram of USA300 LAC WT, its msaABCR-
deletion mutant, its msaABCR complement, its all-protease mutant, and its msaABCR-deletion/all-protease-deletion double 
mutant. Representative results of three individual experiments are shown. (Source: G C et al. 2019, (106)) 
 
Furthermore, zymogram analysis also showed that the processing and/or activity 
of murein hydrolase bands in the msaABCR-deletion/all-protease-knockout strain 
reverted to the wild-type level (Fig. 4.12 B). Increased processing and/or activity of 
murein hydrolase bands in msaABCR-mutant Mu50 cells reverted to wild type levels 
when grown in the presence of a protease-inhibitor cocktail (Fig. 4.12 A). This 
observation further supports our result and confirms our previous findings that increased 
protease activity in the msaABCR mutant is responsible for increased processing and/or 
activity of murein hydrolases. 
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Overall, these findings suggest that the extra murein hydrolases band in 
zymogram analysis produced by the msaABCR mutants in both VISA and MRSA strains 
were due to increased atlA production as well as increased processing of AtlA and/or 
other murein hydrolases by the increased activity of proteases. Therefore, increased 
protease-mediated murein hydrolase activity may be responsible for the defective cell 
wall crosslinking in the msaABCR mutants. 
Previous studies have shown that WTAs are cell-surface glycopolymers that are 
covalently attached to peptidoglycan and modulate AtlA murein hydrolase activity as 
well as its localization (36, 60). In addition, WTAs are also known to play a role in PBP4 
localization, lysozyme resistance, and cell wall crosslinking (18, 19, 119). To examine 
the potential role of WTAs in the msaABCR-mutant cell wall crosslinking defect, we 
estimated the teichoic acid content of the cell wall by measuring the inorganic phosphate 
concentration of WTA extracted from msaABCR mutants in comparison with their wild-
type and complementation strains in the Mu50 (Fig. 4.13 A) and USA300 LAC (Fig. 
4.13 B) backgrounds. We observed a significant reduction in the inorganic phosphate 
concentration of WTA in msaABCR-mutant cells (76%) compared with its wild-type 
(100%) and complementation (98%) counterparts in Mu50. However, we observed a 
significant but smaller difference in inorganic phosphate concentration of WTA between 
the msaABCR mutant (87%) and wild type (100%) in the USA300 LAC background (Fig. 
4.13). This observation suggests that msaABCR mutant might have reduced teichoic acid 
content affecting autolysin activity and crosslinking. However, further investigation is 
required to fully understand the relationship between the decreased WTA content and 





Figure 4. 13 Decreased teichoic acid in msaABCR-mutant cells increases their 
susceptibility to cleavage by murein hydrolases. (A) Comparison of the percentage of phosphate content in 
wall teichoic acid (WTA) in wild type, its msaABCR mutant, and its msaABCR complement in the Mu50 strain background. (B) 
Comparison of the percentage of phosphate content in wall teichoic acid (WTA) in wild type, its msaABCR mutant, and its msaABCR 
complement in the USA300 LAC strain background. These results represent the means of three independent experiments performed in 
triplicate. Error bars represent the standard error. Student’s t-test (OriginPro) and one-way ANOVA were used to compare the results 
of wild-type with its mutant (*p<0.05, **p<0.005, ***p<0.0005). (Source: G C et al. 2019, (106)) 
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1.1 4.2 DISCUSSION 
In this study, we investigated the role of the msaABCR operon in S. aureus cell 
wall biosynthesis and cell wall lysis. We showed that the msaABCR operon mutants have 
reduced cell wall thickness and peptidoglycan crosslinking compared with wild-type S. 
aureus in both MRSA (USA300 LAC) and VISA (Mu50) strains. We have shown that 
the reduced peptidoglycan crosslinking in msaABCR-mutant cells is mainly due to the 
nonspecific processing and/or increased activity of murein hydrolases due to increased 
protease activity. Decreased teichoic acid content in the msaABCR-mutant cell wall may 
also be additional factor for making it more susceptible to lysis by murein hydrolases. In 
addition, transcriptional expression of murA, which is responsible for the early rate-
limiting step in cell wall synthesis, was significantly decreased in the msaABCR mutant 
of both strains. Other early peptidoglycan biosynthesis genes (glmU and murD) were also 
significantly downregulated in the Mu50 msaABCR-deletion mutant but not in the 
USA300 LAC background.  Although we observed decreased PG crosslinking, cell wall 
thickness, and teichoic acid content along with an increased rate of cell wall lysis in the 
msaABCR mutants, these cell wall-associated phenotypes were found to be more 
prominent in the VISA (Mu50) strain than in the MRSA (USA300 LAC) strain. These 
observations correlate with our findings that the msaABCR mutants are more susceptible 
to cell wall-targeting antibiotics, such as vancomycin, methicillin, several β-lactams, and 
the enzyme lysostaphin (Table 4.1). The marked deleterious effects following the 
deletion of msaABCR in both the USA300 LAC and the Mu50 strains under cell wall-
related stresses suggest that a key role of the msaABCR operon is the maintenance of cell 
wall integrity.  
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VISA strains are phenotypically and genotypically different from vancomycin-
susceptible strains (VSSA) strains. Increased cell wall thickness (139), reduced autolysis 
(140), altered cell WTA content (141, 142), and decreased virulence (143) are examples 
of altered phenotypes associated with VISA strains, which have been explained in detail 
in reviews (15, 54). Differentially expressed or mutated genes involved in 
Staphylococcus metabolism (142, 144), cell wall synthetic pathways, and murein 
hydrolases are examples of altered genotypes in VISA strains (15, 54, 142, 145). Mu50 
was shown to have lower autolytic activity in whole-cell lysis assays and  zymogram 
analysis relative to its vancomycin-susceptible counterpart (140). The decreased autolysis 
in VISA strains is thought to contribute to cell wall thickening, leading to increased 
resistance to vancomycin. Increased expression and nonspecific processing of atlA and 
decreased cell wall thickness in the Mu50 msaABCR-deletion strain shows the 
importance of the msaABCR operon in acquiring vancomycin resistance and the 
complexities of autolysis regulation during VISA development. In our studies we also 
observed several distinct and characteristic differences between the USA300 LAC 
(MRSA) and the Mu50 (VISA) strains. The USA300 LAC strain had a shorter lag growth 
phase, a thinner cell wall, increased expression of atlA, increased activity of murein 
hydrolases, and higher susceptibility to cell wall-targeting antibiotics than the Mu50 
strain. We also observed that the cell wall of the msaABCR-deletion mutant of USA300 
LAC was thinner than the cell wall of the msaABCR mutant of the Mu50 strain. With the 
Mu50 strain, we observed increased lysostaphin susceptibility in the msaABCR mutant, 
which was not the case with USA300 LAC. These strain-dependent genotypic and 
phenotypic variations may contribute to some of the differences in phenotype observed 
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between the msaABCR-deletion mutant in the Mu50 (VISA) versus the USA300 LAC 
(MRSA) background—namely, a pronounced reduction in cell wall thickness, cell wall 
lysis rate, teichoic acid phosphate content, and expression of cell wall synthetic and 
hydrolase genes as well as a different lysostaphin lysis pattern. These findings also 
corroborate the finding that deletion of the msaABCR operon has more pronounced 
effects in the Mu50 (VISA) than in theUSA300 LAC (MRSA) strain with cell wall-
related stresses.  
Several studies have established a link between the degree of crosslinking of 
peptidoglycan and resistance to several cell wall-targeting antibiotics, such as β-lactams 
and glycopeptides, in a PBP-independent manner (49, 50, 146). One such study by Baek 
et al. showed that, of the highly conserved, intracellular, ATP-dependent proteases, 
ClpPX affects cell wall thickness, cell wall crosslinking, and the activity of murein 
hydrolases (147). Moreover, altered processing of the major autolysin, AtlA, was also 
observed in the clpP and ClpX mutants (147). In this study we showed that deletion of all 
proteases in the msaABCR mutant reversed the nonspecific processing of murein 
hydrolases and decreased crosslinking, suggesting that the crosslinking defect is a result 
of increased murein hydrolase activity via increased protease activity. Thus, the 
msaABCR operon regulates cell wall crosslinking and cell wall thickness by modulating 
protease activity and murein hydrolase activity, which further confirms the role of 
proteases and the processing of murein hydrolases in cell wall metabolism and antibiotic 
resistance in S. aureus. 
WTAs play a crucial role in septal localization of autolysins in S. aureus cells and 
interact with them, thereby regulating autolysis (36, 49, 60, 61, 128, 148). WTAs are also 
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known to have an important role in peptidoglycan crosslinking, as well as in β-lactam and 
vancomycin resistance determining septal localization of PBP4 and fmtA (14, 18, 19, 58, 
59). The reduction in WTA inorganic phosphate content (surrogate measure of teichoic 
acid content) and the concomitant increase in autolysin activity within the cell wall might 
be responsible for increased peptide chain lysis in msaABCR-mutant cells leading to 
decreased crosslinking. Quantitative real-time PCR analysis showed a consistent but 
small decrease (<2 fold) in gene expression levels of teichoic acid biosynthesis genes 
(tarO and tarA) in msaABCR mutants in both the USA300 LAC and Mu50 strains. 
Caballero et al. also showed that the MsaB protein binds to undecaprenyl-phosphate-N-
acetylglucosaminyl-1-phosphatetransferase (tarO) mRNA (104), suggesting the 
possibility of post-transcriptional regulation of teichoic acid production by the msaABCR 
operon. A bifunctional protein, glmU, catalyzes the de novo biosynthetic pathway for 
UDP-N-acetylglucosamine (UDP-GlcNAc) (138). UDP-GlcNAc is also a precursor for 
WTA, along with peptidoglycan synthesis. Thus, decreased expression of glmU in the 
Mu50 msaABCR mutant may also contribute to decreased teichoic content in the Mu50 
strain. This also correlates with the larger decrease in teichoic acid content in the Mu50 
msaABCR mutant than in the USA300 LAC msaABCR mutant. Given that msaABCR-
mutant cells exhibit a decreased WTA content, this may be an additional contributing 
factor in the decreased crosslinking and increased antibiotic susceptibility observed in 
both the Mu50 and USA300 LAC strain backgrounds.  
   In this study we observed 2.49- and 1.68-fold increases in atlA gene transcription 
levels in the msaABCR-deleted Mu50 and USA300 LAC strains, respectively, compared 
with their respective wild-type strains. A recent study by Caballero et al. showed that the 
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msaB-deletion mutant produces greater amounts of N-acetylmuramoyl-L-alanine 
amidase, sle1, and the bifunctional autolysin atlA, based on their proteomics analysis 
(104). They also showed that the MsaB (also known as CspA) protein binds to these 
mRNAs according to their RNA-binding protein immunoprecipitation-microarray 
profiling (RIP-ChIP) (104). Thus, increased activity of murein hydrolases in the 
msaABCR mutants of both strains may also be due to post-transcriptional regulation by 
the MsaB protein as an RNA chaperone.  
   Bacteria can take up and utilize sugars and amino sugars in the cytoplasm for 
ATP production through glycolysis and the synthesis of bacterial components (e.g., 
peptidoglycan, lipoteichoic acid, WTA, capsule, and nucleic acids (20, 149, 150). UDP-
N-acetylglucosamine serves as a biosynthetic precursor for peptidoglycan, biofilm, the 
bacterial capsule, and teichoic acids (20). Thus, allocation of sugar into different 
pathways is critical for virulence regulation and survival of bacteria (20, 149, 150). 
Several adjustments influencing the balance between cell wall synthesis and hydrolysis 
have been reported, which eventually lead to cell wall thickening in VISA strains 
compared with their counterpart VSSA strains. Also, cell wall synthesis consumes high 
amounts of substrate and energy (54). To build a thickened cell wall, the demand for cell 
wall biosynthetic precursors is increased in VISA strains, which requires adjustments in 
cellular metabolism. These adjustments are directly or indirectly linked to the 
biosynthesis of cell wall precursors (54, 144, 151). Decreased cell wall thickness, 
decreased expression of early cell wall synthetic genes and teichoic acid content, and the 
absence of a capsule in msaABCR-mutant (103) cells suggests the allocation of sugar 
away from the cell envelope synthetic pathway. Therefore, we hypothesize that the 
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msaABCR operon also regulates the allocation and utilization of sugars in different 
pathways. We plan to further investigate the role of msaABCR in the allocation and 
utilization of sugar in several pathways (glycolysis, TCA cycle, gluconeogenesis, and the 
amino sugar pathway) to determine its role in peptidoglycan, teichoic acid, and other cell 
wall-component synthesis as well as in determining cell wall thickness. 
Peptidoglycan is a dynamic structure that undergoes simultaneous synthesis and 
degradation during cell growth. The balance between these two opposing processes is 
essential for maintaining an intact and robust bacterial cell wall. Overall, the defect in cell 
wall integrity in the msaABCR mutants is due to a combination of two contributing 
factors. First, msaABCR-mutant cells have increased extracellular protease activity, 
which leads to increased and unregulated processing of murein hydrolases and 
subsequent autolysis. This results in defective crosslinking of mutant-strain 
peptidoglycan and promotes cell wall lysis, which is enhanced by the decreased teichoic 
acid content within the cell wall. Second, msaABCR mutant cells have significantly 
reduced peptidoglycan synthesis, due to a decrease in transcription of early cell wall-
synthesizing genes (glmU, murA, and murD). Based on these results, we propose that the 
decreased cell wall thickness and antibiotic resistance observed in the msaABCR-mutant 
strain is due to its inability to maintain a balance between simultaneous cell wall 
synthesis and hydrolysis. Our new findings shed light on the role of the msaABCR operon 
in cell wall biosynthesis, autolysis, cell wall integrity, and antibiotic resistance in both 
VISA and MRSA strains. Therefore, we conclude that the msaABCR operon modulates 
β-lactam and vancomycin resistance by keeping a balance between cell wall synthesis 
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and cell wall hydrolysis, which is required for maintaining a robust and thick cell wall in 




CHAPTER V – DELINEATING THE ROLE OF THE msaABCR OPERON IN 
STAPHYLOCOCCAL OVERFLOW METABOLISM DURING BIOFILM 
DEVELOPMENT 
5.1 RESULTS 
5.1.1 The msaABCR operon represses acetate-mediated cell death during biofilm 
formation. 
Previous researches have pointed out that the addition of glucose or antibiotics, 
such as vancomycin, induces biofilm formation in S. aureus (152-155). We recently 
performed biofilm assays under conditions of excess glucose (0.5%) and a sub-inhibitory 
concentration of vancomycin in the USA300 LAC (wild type), msaABCR mutant, and 
complementation strains. The USA300 LAC strain showed significantly induced biofilm 
production in glucose or vancomycin supplemented media, however, under the same 
conditions, biofilm production was not induced in the msaABCR mutant (Fig 5.1). These 
observations collectively suggest role of msaABCR operon in biofilm formation in the 
presence of environmental stressors, such as excess glucose, or sub-inhibitory 




Figure 5.1 Biofilm formation by USA300 LAC (wild type), msaABCR-deletion mutant, 
and complementation strains. Measured biofilm formation in biofilm medium, biofilm medium supplemented with 
excess glucose (0.5%), and biofilm medium supplemented with excess glucose (0.5%) and a sub-inhibitory concentration of 
vancomycin (0.2 µg/mL). Values are shown as the percent activity relative to the wild type strain, USA300 LAC, which was set as 
100%. Each vertical bar represents the mean of three independent experiments. Error bars represent the standard error (SE). Student’s 
t-test and one-way analysis of variance (ANOVA) were used to compare the results for the wild types with their corresponding 
mutants (**p<0.005).  
Previously, we have found an increased cell death phenotype to be associated 
with the msaABCR mutation under both planktonic and biofilm growth conditions (106, 
108, 109). Other studies have shown that aerobic growth of S. aureus in tryptic soy broth 
(TSB) supplemented with excess glucose (>35 mM) adversely affect stationary-phase 
survival of S. aureus, due to accumulation of acetate derived from the incomplete 
catabolism of glucose, thus potentiating cell death (69, 156). Therefore, we assessed the 
survival of the USA300 LAC (wild type), msaABCR mutant, and complementation 
strains during the stationary growth phase in TSB supplemented with 14 mM or 35 mM 
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glucose. In TSB supplemented with 14 mM glucose, all test strains, including the 
msaABCR mutant, demonstrated higher survival during stationary phase over a period of 
5 days compared with growth in TSB supplemented with 35 mM glucose (Fig. 5.1.1 A). 
However, the msaABCR mutant exhibited significantly decreased survival over a period 
of 5 days compared with the USA300 LAC and complementation strains in the presence 
of 35 mM glucose (Fig. 5.1.1 B). Based on these results, we speculated that intracellular 
acidification might be responsible for the reduced survival seen in the msaABCR mutant.   
To assess whether the reduced cell survival of the msaABCR mutant grown in 
excess glucose was indeed caused by intracellular acidification, we performed a cell 
viability assay in TSB supplemented with excess glucose (35 mM glucose) and buffered 
with 50 mM morpholinepropanesulfonic acid (MOPS, pH 7.3). Under these conditions, 
the msaABCR mutant survived better and reverted back to the USA300 LAC (wild type) 
level (Fig. 5.1.1 C). The better survival of the msaABCR mutant in 35 mM glucose-
supplemented medium, buffered to a pH of 7.3 with MOPS, is attributed to failure of 
acetate (pKa = 4.8) molecule to transverse across membrane and cause acidification 
under comparatively neutral environment. Together, these observations indicated that the 





Figure 5. 1.1 Survival of the msaABCR mutant in stationary phase. S. aureus USA300 LAC (wild 
type), msaABCR mutant, and complementation strain cell viabilities (mean ± standard error of the mean) were monitored every 24 h 
over a period of 5 days in TSB plus 14 mM glucose (A), TSB plus 35 mM glucose (B) and MOPS (pH 7.3)-buffered TSB with 35 mM 
glucose (C). Each data point represents the mean of three independent experiments. Error bars represent the standard error (SE). 
Student’s t-test (unpaired) or one-way analysis of variance (ANOVA) were used to compare the results for the wild type with its 
corresponding mutants (*p<0.05, **p<0.005, ***p<0.0005). (Source: Polley et al, 2020 (157)) 
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Studies have shown that when S. aureus is grown aerobically under excess 
glucose conditions, pyruvate is catabolized to acetate via the AckA–Pta and CidC 
pathways (69-71, 73, 92). To examine the role of the msaABCR operon in glucose 
catabolism to acetate, we measured glucose utilization as well as acetate production in all 
the test strains by growing the cells in TSB supplemented with 35 mM glucose for the 
first 24 h of planktonic growth. All the test strains had similar growth until 12 h, but the 
msaABCR mutant showed significantly reduced growth after 24 h (Fig. 5.2 A). When we 
measured the pH of the supernatants collected from cell cultures, we observed similar 
changes in pH over the 24 h among all strains (Fig. 5.2 B). Acetate levels for all the 
strains remained almost constant after 16 h till 24 h suggesting all the strains couldn’t 
reutilize acetate when grown in excess glucose even after depletion of glucose from 
growth medium. We, therefore, did not observe classic diauxic growth under acidic 
growth environment (Fig. 5.2 B and D).  Glucose and acetate kinetics measurements 
showed that the msaABCR mutant consumed glucose and produced acetate significantly 
faster than the USA300 LAC (wild type) and complementation strains after the late-
exponential growth phase (4 h) (Fig. 5.2 C and D). msaABCR mutant consumed most 
glucose before 12 hours of growth and had minimal glucose (~2mM) in medium at 12 
hour, however wild type and complementation strain still had ~4mM glucose even after 
16 hours of growth (Fig. 5.6.4). Since we observed effects of msaABCR deletion after 
late exponential phase (after 4hr) and pH of growth medium reached close to 4.8 at 8 h 
(Fig 5.2.1), we chose period of 4 hour to 8hr to measure rate of glucose consumption and 
acetate production. When we measured the rate of glucose consumption and acetate 
production after the late-exponential growth phase (from 4–8 h of growth), we observed 
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that the msaABCR mutant had a significantly (p<0.0005) increased rate of glucose 
consumption (Fig. 5.3 A) as well as an increased rate of acetate production compared 
with the USA300 LAC (wild type) and complementation strains (p<0.005, Fig. 5.3 B). 
This increased acetate production under lower pH condition, close to pH 4.8 (pKa of 
acetate) indicate an increase in neutral acetic acid which then can diffuse across 
membrane causing intracellular acidification in the mutant compared with the USA300 
LAC (wild type) and complementation strains. Thus, we speculated that the decreased 
viability of the msaABCR mutant during the stationary phase (24–120 h) in TSB 
supplemented with 35 mM glucose (Fig. 5.1.1 B) is due to increased intracellular 





Figure 5. 2 Growth curve, pH kinetics, glucose kinetics, and acetate kinetics of the 
USA300 LAC (wild type), msaABCR mutant, and complementation strains grown 
aerobically in TSB supplemented with 35 mM glucose. The OD600nm (A) and the pH (B) of the culture 
medium were determined at the indicated times. Temporal depletion of glucose from the culture media of the indicated strains (C). 
Temporal accumulation of acetic acid in the culture media of the indicated strains (D). Glucose and acetate concentrations in culture 
supernatants were measured at the indicated growth times in TSB plus 35 mM glucose using a commercially available kit (R-
Biopharm). Each data point represents the mean of three independent experiments. Error bars represent the standard error (SE). 
Student’s t-test (unpaired) or one-way analysis of variance (ANOVA) were used to compare the results for the wild types with their 




Figure 5. 3 Rate of glucose consumption and production of acetate under excess glucose 
conditions by msaABCR mutant. Rate of glucose consumption was measured as the concentration of glucose (mM) 
consumed between 4 h and 8 h of growth, per OD600 at the 8-h time point, per unit time (h) (A). Rate of acetate production was 
measured as the concentration of acetate (mM) produced between 4 h and 8 h of growth, per OD600 at the 8-h time point, per unit 
time (h) (B) in S. aureus USA300 LAC (wild type) and the msaABCR mutant strains. Glucose and acetate concentration in culture 
supernatants were measured at the indicated growth times in TSB plus 35 mM glucose using a commercially available kit (R-
Biopharm). The box indicates the Q1 and Q3 values, while the solid line represents Q2. Student’s t-test (unpaired) or analysis of 
variance (ANOVA) were used to compare the results for the wild types with their corresponding mutants (**p<0.005, ***p<0.0005). 
To assess whether the observed increased consumption of glucose and production 
of acetate in the msaABCR mutant is influenced by culture pH, we again measured 
glucose utilization and acetate production over the first 24 h by growing the cells in TSB 
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supplemented with 35 mM glucose and buffered with 50 mM morpholinepropanesulfonic 
acid (MOPS, pH 7.3) (Fig. 5.4 and 5.4.2). As observed for TSB supplemented with 
glucose without MOPS (Fig 5.3), glucose consumption and acetate production by the 
msaABCR mutant was also significantly higher than for the USA300 LAC (wild type) 
and complementation strains under a similar growth medium buffered with MOPS at pH 
7.3 after the late-exponential growth phase (4 h) (Fig. 5.4). This significantly increased 
difference for the msaABCR mutant is supported by the calculated rates of glucose 
consumption and acetate production during the 4–8 h of growth (Fig. 5.4.1 A and B). We 
also confirmed previous observation that MOPS buffer doesn’t allow to drop culture pH 
below 5.5 despite all the strains producing ~50mM acetate (data not shown) (69). This 
suggests that acetate produced under excess glucose condition buffered with MOPS 
buffer couldn’t produce neutral acetic acid molecule that could passively breach S. 
aureus membrane causing intracellular acidification. However, we found that all test 
strains were able to transport acetate inside cell and reutilize acetate after glucose 
medium was deplete in medium when grown under MOPS-buffered conditions, indicated 
by decreased acetate between the 12-h and 24-h measurements (Fig. 5.4 C and 5.4.2 B). 
Interestingly, the msaABCR mutant reutilized acetate at a significantly faster than the 
USA300 LAC (wild type) and complementation strains (Fig. 5.4 C and 5.4.2 B), and, as 
a result, the mutant’s growth was significantly higher at the 24-h time point (p<0.0005) 
(Fig. 5.4 A).  
Overall, the msaABCR mutant consumed glucose, and produced acetate at a 
significantly faster rate than the USA300 LAC (wild type) and complementation strains. 
Therefore, we conclude that a function of the msaABCR operon involves the repression of 
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glucose consumption and the catabolism of pyruvate to acetate at or after the late-
exponential growth phase even under buffered condition.  
 
Figure 5. 4 Growth curve as well as glucose and acetate kinetics of the USA300 LAC 
(wild type), msaABCR mutant, and complementation strains grown aerobically in TSB 
supplemented with 35 mM glucose and buffered with 50 mM MOPS, pH (7.3). The OD600 of 
the culture medium was determined at the indicated times (A). Temporal depletion of glucose from the culture media of the indicated 
strains (B). Temporal accumulation of acetic acid and reutilization in the culture media of the indicated strains (C). Glucose and 
acetate concentration in culture supernatants were measured at the indicated growth times in TSB plus 35 mM glucose buffered with 
50 mM (MOPS), pH (7.3), using a commercially available kit (R-Biopharm). Each data point represents the mean of three 
independent experiments. Error bars represent the standard error (SE). Student’s t-test (unpaired) or one-way analysis of variance 




Figure 5.4. 1 Rate of glucose consumption and production of acetate by msaABCR 
mutant when grown aerobically in TSB supplemented with 35 mM glucose and buffered 
with 50 mM MOPS (pH 7.3). The rate of glucose consumption was measured as glucose concentration (mM) consumed 
between 4 h and 8 h of growth, per OD600 at the 8-h time point, per unit time (h) (A). The rate of acetate production was measured as 
acetate concentration (mM) produced between 4 h and 8 h of growth, per OD600 at the 8-h time point, per unit time (h) (B) in the S. 
aureus USA300 LAC (wild type) and the msaABCR mutant strains. Glucose and acetate concentration in culture supernatants were 
measured using a commercially available kit (R-Biopharm). The box indicates the Q1 and Q3 values, while the solid line represents 
Q2. Student’s t-test (unpaired) or one-way analysis of variance (ANOVA) were used to compare the results for the wild types with 





Figure 5.4. 2 Glucose and acetate kinetics of the msaABCR mutant in TSB supplemented 
with 35 mM glucose and buffered with MOPS (pH 7.3). Temporal depletion of glucose from the culture 
media of the indicated strains (B). Temporal accumulation of acetic acid and reutilization in the culture media of the indicated strains 
(C). Glucose and acetate concentration in culture supernatants were measured at the indicated times of growth in TSB plus 35 mM 
glucose buffered with 50 mM (MOPS), pH (7.3), using a commercially available kit (R-Biopharm). Each data point represents the 
mean of three independent experiments. Error bars represent the standard error (SE).  
5.1.1.1 Deletion of msaABCR increased glycolytic flux and TCA cycle activity in S. 
aureus. 
Since, msaABCR mutant showed similar survival with wild type strain over the 
period of 5 days when grown in TSB supplemented with 14 mM glucose, we assessed 
growth curve, pH kinetics, glucose kinetics, and acetate kinetics of the msaABCR mutant 
under similar condition over the 24 h period. Growth of S. aureus in TSB supplemented 
with 14 mM glucose showed well known classic diauxic growth, where glucose from 
growth medium was depleted within 7 h followed by growth with reutilization of acetate 
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for mrtabolism by 24 h (Fig 5.5 A-D). We also observed temporal dynamics of acetate 
levels coinciding with pH shift in culture supernatant from 7.2 to 5.0 during acetate 
production and from 5.0 to ~8.5 during its reutilization within 12 h (Fig 5.5 B). However, 
msaABCR mutant consumed glucose at faster rate compared to wild type strains (Fig 5.5 
C, E). We measured glucose consumption rate at 4hr as glucose (mM) consumed per OD 
per time (h) of growth. This result suggested increased glycolytic flux in msaABCR 
mutant compared to wild type. Also, msaABCR mutant produced higher amount of 
acetate during post exponential growth phase. Interestingly, msaABCR mutant also 
consumed acetate at higher rate compared to wild type after glucose from media was 
exhausted (Fig 5.5 D). Decreased acetate in growth medium was also reflected in pH 
changes with time (Fig 5.5 B). Rate of reutilization of acetate is shown to be correlated 
with TCA activity. Thus, we measured aconitase activity at 12hr time point. Results 
showed that increased aconitase activity in msaABCR mutant compared to wild type 
strain (Fig 5.5 F). Therefore, these results suggest increased glycolytic as well TCA flux 





Figure 5. 5 Growth, pH, glucose, and acetate kinetics of the USA300 LAC, msaABCR 
mutant and complementation strains aerobically in TSB supplemented with 14mM 
glucose. The OD600 and the pH of the culture medium were determined at the indicated times (A, B). Temporal depletion of 
glucose from the culture media of those indicated strains (C). Temporal accumulation and depletion of acetic acid in the culture media 
of these indicated strains (D).  Glucose consumption rate at 4hr was calculated as glucose (mM) consumed per OD per time (hr) of 
growth for indicated strains (E). Aconitase activity of the USA300 LAC, msaABCR mutant and complementation strains grown 
aerobically in TSB supplemented with 0.25% (14mM) glucose (F). 1 unit of aconitase activity was defined as 1nmoles aconitate 




5.1.2 The msaABCR operon represses expression of CidR regulon to repress cidC 
mediated acetate-dependent cell death.  
5.2.2.1 The msaABCR operon represses expression of CidR regulon and overflow 
metabolic pathway genes.  
Several studies have shown that cidR, cidABC, lrgAB, pta-ack, and alsSD play 
major roles in the pathways involved in PCD as well as overflow metabolism (69-71, 73, 
75, 83, 92). Thus, we measured the relative expression of these genes using qRT-PCR in 
the msaABCR mutant cultured in TSB supplemented with 35 mM during the late-
exponential growth phase (5 h of growth). Results showed that the relative fold 
expression of genes controlled by the CidR regulon (cidR, cidA, cidC, lrgA, and alsS) 
were increased in the msaABCR mutant compared with the USA300 LAC (wild type) 
strain (Table 5.1). However, expression of the pta, ack, acsA, and pykA genes was not 
altered in the msaABCR mutant (Table 5.1). These results suggest that the msaABCR 
operon represses expression of the genes of the cidR regulon, including the genes of the 
cidABC, alsSD, and lrgAB operons.  
When we measured the expression of genes involving the CidR regulon (cidR, 
cidA, and alsS) in the msaABCR mutant compared with the USA300 LAC (wild type) 
strain in TSB without glucose during the late-exponential growth phase (5-h growth), we 
observed a consistent, small, but statistically insignificant increase (<2) in expression of 
these genes but not to the extent as when grown in TSB supplemented with 35 mM 
excess glucose (Table 5.2). These results suggest a role for glucose or its metabolites in 
msaABCR-mediated regulation of the CidR regulon when faced with the environmental 
stressor of excess glucose. 
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Table 5. 1 Fold change measurement of genes involved in overflow metabolism in the 
msaABCR mutant compared with the wild type USA300 LAC strain. 
Gene name 
Relative gene expression in the msaABCR mutant compared with the 
USA300 LAC (wild type) strain in TSB plus 35 mM glucose  
ack –1.23 ± 0.34 
pta –1.18 ±0.32 
AcsA 1.1 ±0.42 
pykA 1.05 ± 0.17 
cidA 5.5 ±0.58 
cidC 6.9 ± 0.25 
cidR 7.69 ± 0.45 
alsS 2.58 ± 0.20 
lrgA 3.93 ± 0.37 
 
Expression of genes involved in overflow metabolism in the msaABCR mutant relative to the USA300 LAC (wild type) strain grown 
in TSB supplemented with 35 mM glucose. Total RNA was isolated from cells grown to late exponential growth phase (5 h) in TSB 
supplemented with 35 mM glucose. The relative fold change in gene expression was calculated using gyrB as internal control gene. 
The values are the mean ± standard error of the mean for at least three independent experiments. 
Table 5. 2 Expression of genes involved in the cidR regulon in the msaABCR mutant 
relative to the USA300 LAC (wild type) strain grown in TSB without glucose. 
Gene name Relative gene expression in the msaABCR mutant in TSB without glucose 
cidA 1.73 ± 0.25 
cidR 1.82 ± 0.20 
alsS 1.65 ± 0.14 
 
Total RNA was isolated from cells grown in TSB without glucose in the late-exponential growth phase after 5 h of 
growth. The relative fold change in gene expression was calculated using gyrB as internal control gene. Each value is 




5.1.2.2 msaABCR operon represses pyruvate catabolism to acetoin via alsSD 
pathway.  
Since we observed increased expression of alsS gene in msaABCR mutant (Table 
5.1), we also assessed whether the msaABCR deletion affects pyruvate catabolism via the 
AlsSD pathway. For this, we measured acetoin production by growing the cells in TSB 
supplemented with 35 mM glucose at 12 h point. Results showed that the msaABCR 
mutant produced significantly higher amounts (more than 3-fold) of acetoin in the culture 
medium compared with the USA300 LAC and complementation strains (Fig. 5.6 D). 
Therefore, increased expression of two metabolic genes, cidC and alsS in the msaABCR 
mutant compared with the USA300 LAC (wild type) strain also correlated with the 
respective increased acetate (Fig. 5.3D and 5.3.1) and acetoin (Fig. 5.6 D) production 
observed in post-exponential growth phase suggesting important role of msaABCR 
operon in repressing overflow metabolism. 
 
5.1.2.3 The deletion of cidC in msaABCR mutant increases survival and decreases 
acetate production.  
Among the two pathways for acetate production in S. aureus, we observed no 
effects of msaABCR operon deletion in pta-ackA pathway evident by no changes in 
expression of pta and ackA genes. However, we observed increased expression of cidC 
expression in msaABCR mutant (Table 5.1). To examine the role of cidC-mediated 
acetate production in survival of the msaABCR mutant, we introduced a cidC transposon 
mutation in the msaABCR mutant and measured stationary-phase survival of the 
cidC/msaABCR double mutant under excess glucose condition (TSB plus 35 mM 
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glucose) by monitoring the CFU/mL after 72 hours of growth (Fig. 5.6 A). The survival 
of the msaABCR mutant was significantly enhanced by disruption of the cidC gene to 
levels similar to the USA300 LAC (wild type) and cidC mutant strains (p<0.0005) (Fig. 
5.6 A). In addition, acetate measurement in the culture showed that both msaABCR/cidC 
and cidC mutants produced significantly less amount of acetate than msaABCR mutant 
and the USA300 LAC (wild type) strain respectively (p<0.0005), (Fig. 5.6 C, 5.6.1 C, 
and 5.6.2 F). These results suggest that CidC mediated acetate production contributed to 
cell death in both msaABCR mutant and wild type strain under excess glucose condition. 
In addition, increased cidC expression in msaABCR mutant also correlated with increased 
cell death in msaABCR mutant.  
Despite, msaABCR/cidC mutant producing less acetate compared to msaABCR mutant, 
rate of glucose consumption for msaABCR/cidC mutant and msaABCR only mutant were 
comparable (Fig. 5.6 B). This result suggests that msaABCR operon represses glucose 
consumption independent of CidC activity. In fact, msaABCR/cidC mutant produces 
more acetoin compared to msaABCR only mutant (Fig. 5.6 D) suggesting some of the 
carbon in msaABCR/cidC mutant is fluxed toward acetoin pathway when CidC pathway 




Figure 5. 6 Stationary phase survival, rate of glucose consumption, rate of acetate 
production, and acetoin production by indicated mutants. S. aureus USA300 LAC (wild type), 
msaABCR, msaB mutant, cidC mutant, msaABCR/cidC mutant, cidR mutant and msaABCR/cidR mutant strain cell viabilities (mean ± 
standard error of the mean) were monitored after 72 h of growth (A). Rate of glucose consumption for all the strains was measured as 
the concentration of glucose (mM) consumed between 4 h and 8 h of growth, per OD600 at the 8-h time point, per unit time (h) (B). 
Rate of acetate production was measured as the concentration of acetate (mM) produced between 4 h and 8 h of growth, per OD600 at 
the 8-h time point, per unit time (h) (C) in S. aureus USA300 LAC (wild type) and the msaABCR mutant strains. Glucose and acetate 
concentration in culture supernatants were measured at the indicated growth times in TSB plus 35 mM glucose using a commercially 
available kit (R-Biopharm). Temporal accumulation of acetoin in the culture media of the indicated strains at the 12hr time point (D). 
All the strains were grown aerobically in TSB supplemented with 35 mM glucose for these experiments. The box indicates the Q1 and 
Q3 values, while the solid line represents Q2. Student’s t-test (unpaired) or one-way analysis of variance (ANOVA) were used to 




Figure 5.6. 1 Glucose and acetate kinetics of the cidC and msaABCR/cidC mutant in TSB 
supplemented with 35 mM glucose. The OD600nm (A) of the culture medium were determined at the indicated 
times. Temporal depletion of glucose from the culture media of the indicated strains (B). Temporal accumulation of acetic acid in the 
culture media of the indicated strains (C). Glucose and acetate concentrations in culture supernatants were measured at the indicated 
growth times in TSB plus 35 mM glucose using a commercially available kit (R-Biopharm). Each data point represents the mean of 




Figure 5.6. 2 Glucose kinetics, and acetate kinetics of the USA300 LAC (wild type), 
msaABCR mutant, msaB mutant, cidC mutant, msaABCR/cidC mutant, cidR mutant and 
msaABCR/cidR mutant strains grown aerobically in TSB supplemented with 35 mM 
glucose. Temporal depletion of glucose from the culture media of the indicated strains (A, C & E). Temporal accumulation of 
acetic acid in the culture media of the indicated strains (B, D & E). Glucose and acetate concentrations in culture supernatants were 
measured at the indicated growth times in TSB plus 35 mM glucose using a commercially available kit (R-Biopharm). Each data point 
represents the mean of three independent experiments. Error bars represent the standard error (SE).  
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5.1.3 The MsaB directly regulates the CidR regulon to repress overflow metabolism.  
5.1.3.1 msaABCR regulates stationary phase survival and represses overflow 
metabolism via LysR-type transcriptional regulator, CidR. 
To examine whether observed cell death and overflow metabolism phenotypes in 
the msaABCR mutant is due to via the effect of MsaB on the cidR regulator, we created 
msaABCR/cidR:Tn mutant. We assessed several phenotypes including stationary phase 
survival after 72 hours of growth, glucose and acetate kinetics over 24 hours, rate of 
glucose consumption and acetate generation after late exponential growth phase and 
acetoin production after 12 hours of growth in msaABCR/cidR:Tn mutant and compared 
with wild type, msaABCR mutant and cidR: Tn mutant (Fig 5.6.3 A-C, 5.6 A-D and 5.6.2 
C-D). As shown in previous studies (70), deletion of cidR caused significant decrease in 
survival compared to wild type strain as evident by CFU/mL after 72 hours of growth 
(Fig 5.6 A). msaABCR/cidR:Tn mutant showed similar survival to cidR:Tn only mutant 
(Fig 5.6 A). Deletion of cidR didn’t affect rate of glucose consumption and rate of acetate 
consumption compared to wild type level (Fig 5.6 B-C, 5.6.3 A-C, and 5.6.2 C-D). 
However, deletion of cidR in msaABCR mutant reversed back the rate of glucose 
consumption and acetate generation to wild type and cidR mutant level (5.6 B and C). In 
addition, deletion of cidR significantly decreased acetoin production as shown in previous 
studies (Fig. 5.6 D) (70, 73). Deletion of cidR in msaABCR mutant also significantly 
decreased acetoin production compared to msaABCR only mutant (Fig. 5.6 D). 
msaABCR/cidR:Tn mutant showed similar level of acetoin production to cidR:Tn only 
mutant (Fig. 5.6 D). These results suggested that the observed cell death and overflow 
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metabolism phenotypes in the msaABCR mutant is via the effect of msaABCR on the cidR 
regulator. 
 
Figure 5.6. 3 Growth curve glucose and acetate kinetics of the cidR mutant and 
msaABCR/cidR mutant in TSB supplemented with 35 mM glucose. The OD600nm (A) of the culture 
medium were determined at the indicated times. Temporal depletion of glucose from the culture media of the indicated strains (B). 
Temporal accumulation of acetic acid in the culture media of the indicated strains (C). Glucose and acetate concentrations in culture 
supernatants were measured at the indicated growth times in TSB plus 35 mM glucose using a commercially available kit (R-
Biopharm). Each data point represents the mean of three independent experiments. Error bars represent the standard error (SE). 
5.1.3.2 MsaB alone regulates stationary phase survival and represses overflow 
metabolism.  
The msaABCR operon is shown to encode only protein MsaB (100). Noncoding 
RNAs are thought to be essential to regulate the expression of MsaB. MsaB (cspA) 
protein acts as a transcription factor and an RNA chaperone in previous studies (100-
103). Therefore, we next examined the contribution of msaB gene in stationary phase cell 
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death and overflow metabolism.  We deleted only msaB coding region in USA300 LAC 
strain and compared the stationary phase survival at 72-hour, glucose and acetate 
kinetics, rate of glucose consumption, rate of acetate production and acetoin production 
after12 hours of growth in resulting mutant with that of the msaABCR mutant (Fig 5.6.4 
A-C, 5.6 A-D and 5.6.2 A-B). msaB mutant alone showed all those phenotypes similar 
to msaABCR mutant (Fig 5.6.4 A-C, 5.6 A-D and 5.6.2 A-B). These results suggest that 
MsaB protein is essential to determine these phenotypes. 
 
Figure 5.6. 4 Growth curve, and glucose and acetate kinetics of the msaABCR mutant 
and msaB mutant in TSB supplemented with 35 mM glucose. The OD600nm (A) of the culture medium 
were determined at the indicated times. Temporal depletion of glucose from the culture media of the indicated strains (B). Temporal 
accumulation of acetic acid in the culture media of the indicated strains (C). Glucose and acetate concentrations in culture supernatants 
were measured at the indicated growth times in TSB plus 35 mM glucose using a commercially available kit (R-Biopharm). Each data 
point represents the mean of three independent experiments. Error bars represent the standard error (SE).  
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5.1.3.3 MsaB binds to the cidR promoter.  
We performed an electrophoretic mobility shift assay (EMSA) to investigate 
whether MsaB (the only protein product of the msaABCR operon and known 
transcriptional regulator) binds to the promoter region of the cidR, cidABC, and alsSD 
genes, which are important for the regulation of pathways involved in PCD and overflow 
metabolism. We prepared purified MsaB protein and assessed the gel shift of the protein–
DNA complex. We prepared double stranded promoter region probe for each of these 
genes with 5′-biotinylation. The presence of a shifted band as a result of MsaB binding to 
the 5′-biotinylated promoter region was only observed with the cidR gene (Fig. 5.7) and 
not with the promoter regions of the cidABC (Fig. 5.7.1 A) or alsSD (Fig. 5.7.1 B) genes. 
Thus, MsaB has the ability to act as a direct transcriptional regulator of the cidR gene 
only. To determine the specificity of this binding, a 100-fold excess of unlabeled 
PcidR probe was added to the reaction mixture. Addition of this competitive probe 
resulted in an almost complete elimination of the labeled PcidR–MsaB complex band, 
indicating that the non-labelled specific probe competed with the labeled probe for the 
limited amount of MsaB (Fig. 5.7). These results indicate that the MsaB protein binds 
the cidR promoter and that recognition of the promoter is specific. Therefore, we 
concluded that, although MsaB did not bind to the promoter region of the cidABC and 
alsSD operons, however it binds to cidR promoter region suggesting its role as 





Figure 5. 7 MsaB binds to the cidR promoter. Electrophoretic mobility shift assay 
(EMSA) with the cidR promoter. The shifted DNA–protein complex is shown after an increased concentration of 
MsaBhis was incubated with a biotin-labeled cidR promoter target (labeled probe). The gel shift was reversed when 100-fold excess 
concentration of unlabeled cidR promoter probe (unlabeled probe) was added to the reaction mixture, demonstrating that the label did 
not bind nonspecifically to MsaBhis. The assay was performed in a total reaction volume of 20 μl, and the assay mixture was 





    
Figure 5.7. 1 Electrophoretic mobility shift assay (EMSA) with the cidABC (A) and alsSD 
(B) promoter. No shifted DNA–protein complex is observed when an increased concentration of MsaBhis was incubated with a 
biotin-labeled cidABC and alsSD promoter target (labeled probe). The assay was performed in a total reaction volume of 20 μl, and 
the assay mixture was incubated at room temperature for 20 min according to the manufacturer’s instructions (LightShift 
chemiluminescent EMSA kit). 
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5.1.3.4 Increased CidR regulon partially contributes to increased autolysin activity 
in msaABCR mutant under excess glucose condition.  
CidR is shown increase activate murein hydrolase activity when grown under 
excess glucose condition via some unknown mechanism (73). msaABCR mutant is also 
shown to repress murein hydrolase activity in our previous studies (108, 109). To 
examine whether increased murein hydrolase activity in the msaABCR mutant is due to 
via the effect of MsaB on the cidR regulator, we measured murein hydrolase activity in 
msaABCR/cidR:Tn mutant. Deletion of cidR in msaABCR mutant decreased murein 
hydrolase activity compared to msaABCR only mutant (Fig. 5.8) showing that increased 
cidR activity contributes to increased murein hydrolase activity in msaABCR mutant. 
However, msaABCR/cidR:Tn mutant had higher murein hydrolase activity compared to 
cidR:Tn only mutant (Fig. 5.8). This observation also suggests the existence of other 




Figure 5. 8 Quantitative murein hydrolase assay. 100µg extracellular proteins extracted from 16 h cultures of 
USA300 LAC, msaABCR mutant, cidR:Tn mutant and msaABCR/cidR:Tn mutant grown in TSB supplemented with 35 mM glucose 
were each added to a 1mL 1mg/mL M. luteus cell suspension. Murein hydrolase activity of each sample was measured as a decline in 
OD600 of cell suspension at every 30 min over a 3 h time period. Each data point represents the mean of three independent 
experiments. Error bars represent the standard error (SE). 
5.1.4 Pyruvate induces expression of msaABCR operon to repress growth and 
pyruvate catabolism under excess-pyruvate conditions in the post-exponential 
growth phase. 
We observed a significant increase in expression (4.7-fold) of the msaB gene 
when grown in TSB supplemented with 35 mM glucose compared with TSB without 
excess glucose in the USA300 LAC (wild type) strain (Table 5.3). We also confirmed 
activation of the CidR regulon with glucose (Table 5.3), as shown in previous studies of 
the importance of glucose and/or its metabolites in the regulation of the CidR regulon 
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(69, 72, 73). It has been speculated that during overflow metabolism, when grown in 
medium with excess glucose, carbon catabolite repression may result in accumulation of 
intracellular pyruvate from glucose catabolism in S. aureus cells (114, 158). To 
determine whether induction of msaABCR expression by excess glucose occurs via its 
catabolism to produce excess intracellular pyruvate, we measured the relative gene 
expression of the msaABCR operon genes (msaA, msaB, msaC) in the USA300 LAC 
strain using qRT-PCR after 5 hours of growth in TSB without glucose supplemented with 
2% pyruvate compared to when grown in TSB without glucose (Table 5.3). Results 
showed that the relative expression levels of the msaABCR operon genes are significantly 
increased when 2% pyruvate is added to TSB without glucose compared with control (no 
pyruvate), suggesting that pyruvate induces expression of the msaABCR operon (Table 
5.3).  
Table 5. 3 Expression of the msaABCR operon in the USA300 LAC strain with increased 
intracellular pyruvate. 
Gene name 
Relative expression of the msaABCR operon in the USA300 LAC strain 
when grown in 2% pyruvate-supplemented TSB without glucose relative to 
TSB without glucose (mean ± SDE). 
SAUSA300_1296 (msaA) 6.23 ± 0.51 
SAUSA300_1295 (msaB) 3.59 ± 0.11 
SAUSA300_1294 (msaC) 2.1 ± 0.22 
 
Fold change measurement of the msaABCR operon in the USA300 LAC strain when grown in 2% pyruvate-supplemented TSB without 
glucose compared with TSB without glucose. Total RNA was isolated from cells grown to late-exponential growth phase at the 5-h time 
point using the RNeasy RNA extraction kit (Qiagen). The relative fold change in gene expression was calculated using gyrB as internal 




Table 5. 4 Expression of the cidR regulon in the USA300 LAC (wild type) strain when 
grown in the presence of excess glucose. 
Gene name 
Relative gene expression in TSB medium supplemented with 35 mM glucose 
relative to TSB without glucose (mean ± SDE). 
cidA 7.28 ± 1.23 
cidR 2.39 ± 0.31 
alsS 5.95 ± 0.73 
msaB 4.71 ± 0.32 
 
Fold-change measurement of expression of the msaABCR operon and cidR regulon in the USA300 LAC strain when grown in TSB 
supplemented with 35 mM glucose relative to TSB without glucose. Total RNA was isolated from cells grown to late-exponential 
growth phase at the 5-h time point using the RNeasy RNA extraction kit (Qiagen). The relative fold change in gene expression was 
calculated using gyrB as the internal control gene. Each value is the mean ± standard error of the mean for at least three independent 
experiments. 
We also measured MsaB production in USA300 LAC cells grown under the 
following conditions by western blot: TSB without glucose (control), TSB without 
glucose supplemented with 2% pyruvate, and TSB supplemented with 35 mM excess 
glucose. We confirmed that the increased expression of the msaB gene observed in cells 
grown in the presence of 2% pyruvate-supplemented TSB without glucose (Table 5.3) 
and in 35 mM glucose-supplemented TSB (Table 5.4) compared with the cells grown in 
TSB without glucose also resulted in significantly increased production of MsaB protein 
under the same conditions (Fig. 5.9). These results show that pyruvate induces both 





Figure 5. 9 Western blot of USA300 LAC whole-cell lysates probed with an anti-His 
antibody. Cells were harvested from USA300 LAC msaABhisCR complementation cells grown in the presence of TSB without 
glucose, TSB supplemented with 35 mM glucose, and in TSB without glucose supplemented with 2% pyruvate. Cells were lysed, and 
25 µg protein was loaded in each lane. These results are representative of three independent experiments for each sample set.  
Since we observed that pyruvate induces msaABCR expression and MsaB 
production, we tested the msaABCR mutant’s growth and pyruvate catabolism to acetate 
when cultured under increased intracellular pyruvate conditions (TSB with 1% pyruvate) 
after 5 h of growth (Fig. 5.10). There was no statistical difference in USA300 LAC strain 
growth (measured at OD600nm) between TSB and TSB supplemented with 1% pyruvate. 
The msaABCR mutant’s growth was slightly lower than for the USA300 LAC (wild type) 
strain when grown in the presence of TSB. However, the msaABCR mutant’s growth was 
significantly increased in TSB supplemented with 1% pyruvate relative to TSB (p<0.05), 
although growth of the msaABCR mutant remained similar under both conditions (Fig. 
5.10 A). We also measured the amount of acetate (product of pyruvate catabolism) 
produced under the same conditions. While all strains showed the same levels of acetate 
production in the control TSB medium, the addition of 1% pyruvate to the TSB medium 
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resulted in the msaABCR mutant producing more acetate than the USA300 LAC (wild 
type, p<0.005) and complementation strains (Fig. 5.10 B).  
Previously, we showed that the msaABCR mutant has increased protease activity, 
which modulates murein hydrolase activity (108). Other studies have shown that 
increased concentrations of intracellular pyruvate induce extracellular proteases (94). In 
order to discern the effect of increased protease activity in the msaABCR mutant, we 
studied growth in TSB supplemented with 1% pyruvate using our currently tested strains 
combined with an all-protease-knockout strain (LAC all-protease mutant, msaABCR/all-
protease double mutant, and msaABCR/all-protease double mutant complementation 
strains). We observed that the msaABCR/all-protease mutant showed significantly 
increased growth in TSB supplemented with 1% pyruvate compared with TSB (p<0.005), 
while no difference was observed in the growth of the LAC all-protease mutant under the 
same conditions (Fig. 5.10 A). In addition, the msaABCR/all-protease mutant produced 
significantly more acetate when grown in TSB supplemented with 1% pyruvate 
compared with the all-protease mutant (p<0.005) and complementation strains (Fig. 5.10 
B). These results show that increased intracellular pyruvate concentration induces MsaB 
production then thereby represses pyruvate catabolic pathway and growth when grown 




Figure 5. 10 OD600 and acetate accumulation by the USA300 LAC (wild type), 
msaABCR-deletion mutant, and complementation strains under increased intracellular 
pyruvate conditions. OD600 (A) and temporal accumulation of acetic acid (B) in the culture media of the indicated strains 
when grown in the indicated growth media at the 5-h time point. Acetic acid in the culture media of the indicated strains when grown 
in TSB supplemented with 1% pyruvate at the late-exponential growth phase (5-h time point). Acetate in culture supernatants was 
measured at the indicated growth times using a commercially available kit (R-Biopharm) (B). Each vertical bar represents the mean of 
three independent experiments. Error bars represent the standard error (SE). Student’s t-test (unpaired) or one-way analysis of 





In this investigation, we showed the role of the msaABCR operon in regulation of 
the CidR regulon, which affects programmed cell death during biofilm development as 
well as pyruvate catabolism during overflow metabolism. Previously, we showed that 
deletion of the msaABCR operon results in a defective biofilm phenotype, with a 
significantly increased dead cell biomass and decreased biofilm thickness (100, 108). 
Excess glucose and sub-inhibitory concentrations of antibiotics are known to enhance 
biofilm development (152, 153, 159, 160), but these conditions failed to enhance biofilm 
development in the msaABCR mutant (157). However, consistent with previous studies, 
we did observe induced biofilm formation in the USA300 LAC (wild type) strain under 
these conditions, thus indicating that the msaABCR operon plays a role in antibiotic- and 
glucose-induced biofilm formation. Diabetes mellitus is known as a major risk factor in 
bacterial infections, such as pneumonia, urinary tract infections, blood stream infections, 
and a chronic foot infection known as diabetic foot (161-164). Very few published 
studies have explored the mechanisms of biofilm formation resulting from diabetes and 
improper antibiotic treatment at sub-inhibitory concentrations; however, they have 
indicated the role of cidA-mediated induction of biofilm development under these 
conditions (152, 159). Defective biofilm development in the msaABCR mutant under 
normal, excess-glucose, and sub-inhibitory antibiotic stress conditions suggest that the 
msaABCR operon is essential for establishing staphylococcal biofilm infections.  
The presence of extracellular DNA and pronounced cell lysis and cell death 
during S. aureus biofilm development has suggested the existence of a bacterial PCD 
during biofilm formation (65, 69, 76, 114, 158). In addition, cidA‐regulated autolysis/cell 
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death to release extracellular DNA (eDNA) has been shown to be a important factor in 
vancomycin‐induced biofilm development (152, 159, 160). Whereas the process of cell 
death is essential for adequate biofilm formation, as it releases the necessary constituents 
(such as eDNA) that compose the extracellular matrix, a homeostatic balance must be 
maintained between the dying and growing cells for proper biofilm development (65, 68, 
69, 114, 158). Thus, increased cell death in msaABCR mutant during biofilm 
development suggest that the msaABCR operon plays an important role in maintaining a 
balance between cell death or autolysis and cell growth during normal biofilm 
development and antibiotic stressor-induced biofilm development. 
It has also previously been shown that the gene expression dynamics of cidR, 
cidABC, and alsSD observed in staphylococcal biofilm microcolonies are mimicked 
during planktonic growth in TSB supplemented with >35 mM glucose (69). Therefore, to 
better understand the mechanism of msaABCR operon regulation of biofilm formation 
and investigate its role in programmed cell death, we studied stationary-phase survival 
(Fig. 5.1), overflow metabolism (Fig. 5.2 to 5.4), and transcription of genes controlled by 
the CidR regulon (Table 5.1) in the msaABCR mutant in TSB supplemented with excess 
glucose. It has been established by many studies that a subpopulation of cells within a 
staphylococcal biofilm undergoes programmed cell death to promote biofilm 
development (68, 69, 152, 159, 165). These investigators have proposed that acetic acid 
(produced during glucose catabolism) accumulates in biofilm microcolonies, creating 
acidic microenvironments due to low diffusion within the biofilm structure. Under an 
environment with a pH close to the pKa of acetate (~4.8), acetate is protonated to its 
neutral acetic acid form, which can easily diffuse through a subpopulation of cells in 
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microcolonies. Increased localized accumulation of acetic acid within these 
microcolonies then increases intracellular acidification, which can lead to unfolding or 
misfolding of proteins and reduce the functionality of the electron transport chain, which 
can, in turn, result in increased production of reactive oxygen species (ROS) and 
ultimately cause cell death in S. aureus (65, 69, 70, 114). This study showed that the 
msaABCR mutant consumes glucose and produces acetate significantly higher rates than 
the wild-type USA300 LAC strain during overflow metabolism (Fig. 5.2 and 5.3), thus 
supporting our suggestion that increased acetate production is responsible for increased 
cell death in the msaABCR mutant. msaABCR/cidC: Tn mutant produced significantly 
less amount of acetate compared to msaABCR mutant (Fig. 5.6 C, 5.6.1 A-C). Stationary-
phase survival of the msaABCR mutant was also reversed back to the USA300 LAC (wild 
type) level when we introduced the cidC mutation in the msaABCR mutant (Fig. 5.6 A), 
These observations thus suggest that increased acetate production in the msaABCR 
mutant via the CidC pathway contributes to increased weak acid-dependent cell death in 
the msaABCR mutant. Previously, our lab showed the msaABCR operon to be defective 
in the oxidative stress response (101). The inability of the msaABCR mutant to cope with 
acetate-mediated ROS oxidative stress may also contribute to increased cell death in the 
msaABCR mutant. Interestingly, deletion of cidC in msaABCR mutant didn’t reduce rate 
of glucose consumption compared to msaABCR mutant despite producing less acetate. In 
addition, msaABCR/cidC double mutant still produced a significantly greater amount of 
acetoin than the cidC mutant suggesting that the excess pyruvate (resulting from excess 
glucose) was funneled through the AlsSD pathway to produce acetoin when acetate 
formation by the CidC pathway was blocked by deletion of cidC gene (p<0.0.005). This 
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indicating a further role of msaABCR operon in repression of pyruvate catabolism and 
maintenance of pyruvate homeostasis. 
msaB mutant alone showed all stationary phase survival and overflow metabolism 
phenotypes comparable to msaABCR mutant (Fig 5.6A-D, 5.6.4 A-B, and 5.6.2 A-B). 
These results suggest that MsaB is major determinant of overflow metabolism. We also 
showed that MsaB acts as transcriptional regulator of cidR (Fig. 5.7). Previous studies 
have shown that cidR as a transcriptional activator of cidABC, and alsSD operons during 
overflow metabolism (69, 70, 75). Since deletion of msaABCR increases expression of 
cidR, we speculated that MsaB act as negative transcriptional regulator of cidR and MsaB 
represses cidABC and alsSD expression and its phenotypes via its activity as 
transcriptional repressor of CidR. When we compared several phenotypes including 
stationary phase survival after 72 hours of growth, glucose and acetate kinetics over 24 
hours, rate of glucose consumption and acetate generation after late exponential growth 
phase and acetoin production after 12 hours of growth between msaABCR/cidR:Tn 
mutant and msaABCR mutant,  we found that deletion of cidR in msaABCR mutant 
reverses these phenotypes to cidR only mutant level (Fig 5.6 A-D, 5.6.2 C-D, and 5.6.3 
A-C). These results suggested that the observed cell death and overflow metabolism 
phenotypes in the msaABCR mutant is via the effect of MsaB on the cidR regulator. 
CidR has been shown to activate the expression of two operons, cidABC and alsSD, that 
display pro- and anti-death functions, respectively (69, 70, 73, 75). These two operons are 
shown to play important role in catabolism of pyruvate. alsSD operon encodes for 
acetolactate synthase and acetolactate decarboxylase required for conversion of pyruvate 
to the neutral by-product, acetoin, whereas the cidC encodes pyruvate:menaquinone 
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oxidoreductase for decarboxylation of pyruvate to acetate (69, 70, 73, 75). Several studies 
suggest that metabolic activities of the alsSD and cidC gene products plays important role 
in determining direction of carbon flux at the pyruvate node, determining fate of cell 
when grown aerobically in excess glucose (69, 70, 75).CidABC operon is shown to be 
transcribed into two different overlapping transcripts denoted as cidABC and cidBC 
depending on growth conditions. Sigma factor B is shown to activate 
Smaller cidBC transcript produced during exponential growth phase, while LTTR family 
transcriptional regulator, CidR, induces the full-length cidABC transcript at late 
exponential growth phase with the acidification of the culture medium by acetate when 
grown under excess glucose condition (70, 73). Recent study by Chaudhari et al. 
provided a new mechanistic insight into understanding of the contribution of individual 
Cid proteins to carbon flux at the pyruvate node. Their study argued that CidR induced 
cidABC transcript, have nominal effect in acetate production. Even though we found 
similar observation that deletion of cidR in S. aureus doesn’t affect overall acetate 
production, rate of acetate production as well as rate of glucose consumption. However, 
our study provides contrasting evidence against the assumption that cidABC transcript, 
have nominal effect in acetate production. In fact, increased cidR expression in msaABCR 
mutant led to increased cidABC transcription producing increased acetate. In addition, 
deletion of cidR in msaABCR mutant reversed back the rate of glucose consumption and 
acetate generation to wild type and cidR mutant level (5.6 B and C). Observed no 
difference in overall acetate production by cidR mutant might be due to redundant 
pathway for acetate production (pta-ackA) as well as redundant expression of cidC (SigB 
dependent CidBC expression). In addition, deletion of cidR significantly represses alsSD 
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expression causing decreased pyruvate catabolism via AlsSD route. This may lead to 
increased pyruvate at pyruvate node leading to increased carbon flux towards acetate 
production pathway. Decreased pyruvate flux via alsSD pathway and increased carbon 
flux towards acetate production in cidR mutant may be the actual reason for increased 
cell death in cidR mutant when grown aerobically in excess glucose condition. 
Studies have shown that an acidic pH inside microcolonies can activate the CidR 
regulon in the subpopulation of cells (69). This activation leads to a production of acetate 
to toxic level via increased CidC activity. Cell death occurs in cells whose repair 
mechanism is exhausted by toxic effects of acetate accumulation and increased cidABC 
operon stress (69, 84). Our study also supports the hypothesis that expression of the 
cidABC operon contributes to increased cell stress (69-71). Thus, regulation of cidR 
expression plays an important role in determining the fate of staphylococcal cell. Our 
results suggests that the msaABCR operon, through direct binding of MsaB to the cidR 
promoter (Fig. 5.7), plays an important role in controlling cidR expression to limit 
acetate-dependent potentiation of cell death. Thus, the msaABCR operon has an important 
role in limiting cidABC-mediated cell stress and thereby controlling cell death in S. 
aureus. Chaudhari et al. have argued against the hypothesis that cidABC operon 
contributes to increased cell stress (70). They showed that deletion of cidB gene 
decreased CidC activity and increased acetoin production, while deletion 
of cidA increased CidC activity and decreased production of acetoin (70). They 
hypothesized that CidA and CidB proteins modulates CidC activity via unknown 
posttranscriptional mechanism (70).  They argue that major role of the CidR regulon is to 
repress acetate-mediated cell death under carbon overflow conditions via activity of cidA. 
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However, we showed contrasting evidence against this argument, we agree with the 
observation that deletion of cidA or cidB might result in altered CidC activity. We think 
that altered structure of cidABC and cidBC transcripts in cidA and cidB mutants may 
affect cidC translation leading to altered CidC activity. 
In our previous study, we showed that the msaABCR mutant has increased 
expression of cell wall-bound and extracellular murein hydrolases, whose activity was 
further increased by enhanced extracellular protease activity (106, 108). We also showed 
that deletion of all proteases in the msaABCR mutant decreased dead cells in msaABCR 
mutant biofilm (106, 108). CidR is also shown to activate murein hydrolase activity when 
grown under excess glucose condition via some unknown mechanism (73). Deletion of 
cidR in msaABCR mutant decreased murein hydrolase activity compared to msaABCR 
only mutant (Fig. 5.8). However, msaABCR/cidR:Tn mutant had higher murein hydrolase 
activity compared to cidR:Tn only mutant (Fig. 5.8). These observations suggest that 
CidR mediated murein hydrolase activity partially contributes to the increased murein 
hydrolase activity in msaABCR mutant, and the existence of other mechanism of 
msaABCR operon in repression of murein hydrolase activity. 
It has been speculated that, during overflow metabolism, carbon catabolite 
repression may result in the accumulation of intracellular pyruvate (114, 158). Pyruvate is 
the intermediate branching point for glucose, lactate, acetate, fatty acid, carotenoid, and 
amino acid syntheses (81, 93, 94). Interestingly, two genes, cidC (pyruvate:menaquinone 
oxidoreductase) and alsSD (α‐acetolactate synthetase/decarboxylase), under control of 
the CidR regulon also utilize the same substrate, pyruvate, producing acetate and acetoin, 
respectively (69, 71, 73, 92). Several studies have speculated that pyruvate is an inducer 
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molecule for activation of cidR expression when grown in excess glucose under acidic 
conditions (69, 75). Thus, pyruvate is the central metabolite directing overflow 
metabolism. Because it is at the junction of several essential pathways in S. aureus cells, 
tight control of pyruvate homeostasis and its fate is crucial to metabolic adaptability in S. 
aureus. In this study, we showed that pyruvate induces expression of the msaABCR 
operon and subsequent MsaB production. In turn, the msaABCR operon directly represses 
pyruvate catabolic pathways through MsaB binding to the cidR regulon promoter, further 
repressing expression of pyruvate catabolic enzymes via the cidC and alsSD pathways. 
Thus, these results suggest that the msaABCR operon might respond to intracellular 
pyruvate concentration, which would allow it to direct optimal expression of cidR to 
regulate programmed cell death during biofilm development and pyruvate catabolism, 
thereby maintaining pyruvate homeostasis. However, a detailed analysis regarding 
intracellular pyruvate sensing by MsaB requires further study. 
In conclusion, this study suggests that the msaABCR operon regulates the process 
of weak acid-dependent cell death in S. aureus. This study also showed that the 
msaABCR operon directly represses the cidR regulon to repress pyruvate catabolism 
during overflow metabolism. Our new findings help decipher the role of the msaABCR 
operon in staphylococcal overflow metabolic adaption during biofilm development as 
well as in pyruvate catabolism and maintenance of pyruvate homeostasis (Fig. 5.11). We 
further seek to define the mechanism of sensing the central metabolite, pyruvate, by the 
msaABCR operon. Continued research is crucial for understanding S. aureus metabolic 
adaptation during chronic infection and for developing future alternative treatments to 




Figure 5. 11 MsaB regulatory pathway during staphylococcal overflow metabolism. 
Pyruvate induces the expression of MsaB production, which in turn represses pyruvate catabolic pathways via the cidC and alsSD 
pathways by repressing CidR activity. 
Lastly, we observed increased glycolytic flux as well as increased acetate 
production at exponential growth phase when grown in 14mM glucose (normal glucose 
condition) (Fig 5.5). We also observed increased acetoin production when grown in 
presence of 14mM glucose at exponential phase (data not shown). These results suggests 
that glycolytic flux are more directed toward carbon catabolic pathways than 
macromolecule synthesis pathway including PG and WTA. Cell wall synthesis is 
expensive process consuming excessive substrate and energy (54). To build a thick cell 
wall, high amount of cell wall biosynthetic precursors are required needing adjustments 
in cellular metabolism. These adjustments are directly or indirectly linked to the 
increased biosynthesis of cell wall precursors and decreased carbon catabolic pathways 
(54, 144, 166). In addition, recent study by Yoshikazu et al. showed that the blocking cell 
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wall synthesis with β-lactam antibiotics, or gene deletion results in an increased flux 
through glycolysis leading to the increased production of reactive oxygen species from 
the respiratory chain (167). These studies suggest close relation between cell wall 
synthesis and staphylococcal metabolism. Thus, increased flux of glycolysis towards 
catabolic pathway than synthesis of PG and WTA precursor may also contribute towards 





CHAPTER VI - CONCLUSION AND FUTURE DIRECTIONS 
All results reported in this dissertation revealed that msaABCR play important role 
in acquiring resistance and biofilm development. We reported decreased cell wall 
thickness, decreased crosslinking in msaABCR-mutant cell wall as well as decreased 
expression of early cell wall synthesizing genes in both clinically relevant antibiotic 
resistant strains (USA300 LAC and Mu50).  We also showed that increased murein 
hydrolase activity and/or nonspecific processing of murein hydrolases mediated by 
increased protease activity in mutant cells lead to decreased crosslinking in cell wall. The 
defect was enhanced by a decrease in teichoic acid content in the msaABCR mutant cell 
wall. Based on these observations we conclude that the msaABCR operon controls the 
balance between cell wall synthesis and cell wall hydrolysis, which is required for 
maintaining a robust cell wall and acquiring resistance to cell wall-targeting antibiotics, 
such as vancomycin and the β-lactams. 
This dissertation further elucidated the mechanism of the cell death phenomenon 
and overflow metabolism at the molecular level in the USA300 LAC strain. We 
uncovered role of msaABCR operon in weak acid-dependent cell death. We showed 
direct repression of cidR regulon by MsaB showing its importance in overflow 
metabolism and programmed cell death during biofilm development in S. aureus. We 
also showed role of MsaB in indirect repression of pyruvate catabolism via cidR. In 
addition, we provided preliminary evidences on how msaABCR operon responses to 
intracellular pyruvate in S. aureus affecting staphylococcal metabolic adaption during 
biofilm development.  
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Our observations of in vitro studies suggest that the msaABCR operon have 
important function in S. aureus metabolic adaptation during biofilm development and 
adaptation in presence of antibiotic stress during infection. However, function of 
msaABCR adaptive mechanism inside the host cells remains yet to be explored. 
Therefore, understanding how msaABCR senses the environmental as well as nutritional 
cues to dictate virulence and stress responses against environmental, host immune and 
antibiotic stresses in vivo will give valuable knowledge on pursuing msaABCR as a drug 
target.   
In addition, our preliminary studies showed that pyruvate induces msaABCR 
expression. And msaABCR operon represses pyruvate catabolism and growth in the 
presence of excess pyruvate. However, mechanism of regulation of MsaB expression by 
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